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1. Summary 
 
Background: The investigation of antibacterial responses is one of the oldest and 
most imporant questions in immunology. Since Metchnikoff, phagocytes were 
pinpointed to be responsible for defense against invading bacterial pathogens by 
engulfment and digestion. However, although much information exists on specific 
molecular mechanisms on the single cell level, phagocyte kinetics in the organs or 
their origin and destination during bacterial infections remain largely uncharacterized, 
although they are probably essential to understand the respective immune 
responses. We have therefore characterized kinetics of granulocytes during and after 
bacterial and viral infections and after stimulation with Toll like receptor ligands. 
Methods: For characterization and enumeration of granulocytes, we used FACS 
technology with peripheral blood and bone marrow samples. To further investigate 
fate of granulocytes in tissues, immunohistochemistry was used. When necessary, 
bacterial counts were measured by serial plating of organ homogenates on agar. 
Cytokines were measured by ELISA technology. 
Results: The first project “Exhaustion of bone marrow granulocyte numbers during 
uncontrolled bacterial infections” used a systemic bacterial infection and revealed a 
reduction of viable granulocytes in the bone marrow that correlated directly with the 
bacterial load in infected spleen and liver (Manuscript in preparation). 
In the second part of this work “Increased susceptibility to bacterial superinfection as 
a consequence of innate antiviral responses”, a virus infection was given prior to 
bacterial superinfection. Virus infection led to apoptosis and decreased numbers of 
granulocytes in the bone marrow by interferon type I induction. During this 
granulocytopenia, bacterial superinfection was greatly facilitated. This paper has 
been published in Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15535-9. Epub 
2006 Oct 9. 
In a third project “Disruption of the bone marrow granulocyte supply and uncontrolled 
bacterial proliferation by TLR2 activation”, an innocuous bacterial infection was given 
and systemic stimulation of TLR2 performed. Thereafter, bone marrow granulocytes 
underwent apoptosis and the bacterial infection became uncontrollable (Manuscript 
in preparation). 
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In the fourth part, we stimulated the innate immune system with lipopolysaccharide 
and determined whether lasting changes occurred. We found that a prolonged innate 
reactivity resulted that led to increased anti-bacterial resistance and survival. This 
work is currently still in progress.  
Conclusion:  The cellular kinetics of granulocytes were found to be volatile and 
crucial for the outcome of bacterial infection. The observed activation-associated 
apoptosis of bone marrow granulocytes by interferon and toll like receptors could be 
of some importance in survival of infections and probably should be investigated 
closer in humans. 
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2. Abbreviations: 
 
Ab Antibody 
APAAP Alkaline phosphatase 
AS Aminoacid 
BSA Bovine Serum Albumine 
C. elegans Caenorhabditis elegans 
CD Cluster Designation 
CD115 M-CSF receptor, expressed on monocytes 
CD11b ß2-integrin on the surface of macrophages, monocytes and 
granulocytes 
 
CD4+ CD4 antigen positive cells, T helper cells 
CD8+ CD8 antigen positive cells, cytotoxic T cells 
Cfu Colony forming units (for bacterial titers) 
DNA Desoxyribonucleinacid 
Drosophila Drosophila melanogaster 
ECACC European Collection of Animal Culture Cells, Salisbury, UK 
FACS Fluorescence activated cell sorting 
FCS Fetal Calf Serum 
FSL-1 Ligand based on the Mycoplasma salivarium lipoprotein 
with the formula S-(2,3-bispalmitoyloxypropyl)-Cys-Gly-Asp-
Pro-Lys-His-Pro-Lys-Ser-Phe 
 
G-CSF Granulocyte-colony stimulating factor 
GM-CSF Granulocyte/monocyte-colony stimulating factor 
GR-1 Granulocyte antigen 1 
HRP Horse Radish Peroxidase 
IFN Interferon 
IFN type I IFN α/β 
IFN type II IFN γ 
Ig Immunglobulin 
IHC Immunohistochemistry 
IL Interleukin 
L.m. Listeria monocytogenes 
LCMV Lymphocytic choriomenigitis virus 
LPS Lipopolysaccharide, TLR4 ligand 
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Ly-6C 
 
Surface antigen specific for murine monocytes (high 
expressors) and granulocytes (intermediate expressors) 
 
Ly-6G Surface antigen specific for murine granulocytes 
M. Morbus 
M-CSF Multi-colony stimulating factor 
Pam2Cys Lipopeptide consisting of Palmitoyl side chains acid and a 
cysteine: S-(2,3-bis(palmitoyloxy)propyl)cysteine, TLR2/6 
ligand 
 
Pfu Plaque forming units (for virus titers) 
Poly(I:C) Double strand RNA consisting of Inosins and Cytosins 
RNA Ribonucleinacid 
Rpm Rounds per minute 
S. aureus Staphylococcus aureus 
S. typhimurium Salmonella typhimurium 
SIRS Systemic inflammatory response syndrome 
TLR Toll like receptor 
TLR 2/6 TLR2 dimerizes with TLR6, binds bacterial and fungal 
lipopeptides  
 
TLR3 TLR3 binds double-stranded RNA, i.e. Poly(I:C) 
TLR4 TLR4 binds lipopolysaccharide 
TNF Tumor necrosis factor 
VSV Vesicular stomatitis virus 
VRSA Vancomycin resistant staphylococcus aureus 
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3. Introduction 
 
3.1 Evolution of infections and early defense mechanisms 
Parasitic-host relationships have developed between organisms early in evolution of 
biological systems (Remy, Taylor et al. 1994). Resisting invasion and digestion by 
other life forms is a crucial factor for evolutionary success in all species, from 
molluscs to homo sapiens (Boots and Bowers 1999; Ellis, Dodds et al. 2000; Boots 
and Bowers 2004). Organisms engaging in infectious behaviour have been identified 
starting from viruses, the lowest known life forms, to highly evolved multicellular 
eukaryontic organisms. The most common and dangerous infections in humans are 
by bacteria, which have represented a great scourge and were very difficult to cure 
until the discovery of penicillium by Alexander Fleming in 1928. Before this time, 
treatment consisted mainly in administration of carbolic acid (Cheyne 1895), iodine, 
bismuth salts, zinc compounds, formaldehyde and heat (Pilcher 1899). For over 50 
years now, antibiotics have greatly reduced the number of deaths due to bacterial 
infections. However, many of the common bacterial strains that were feared before 
penicillium are now slowly acquiring resistance genes to many antibiotics (Chang, 
Sievert et al. 2003; Whitener, Park et al. 2004). Due to this increasing problem, new 
interest has arosen to understand and influence the immunological events occuring 
in anti-bacterial responses.  
The archetypical defense weapon against parasitic invasion by other organisms is 
the phagocytic cell (Metchnikoff 1905). Even a rather primitive organism, the 
nematode C. elegans that is lacking blood circulation and immune cells, has 
phagocytotic, although not specialized cells (Kinchen, Cabello et al. 2005). The fruit 
fly Drosophila melanogaster harbors so-called specialized plasmatocytes, which 
have high phagocytic activity (Franc 2002; Meister 2004). Phagocytes lack adaptable 
antigen receptors and have to rely on pattern recognition. Invariable receptors 
recognise molecular patterns of invading organisms and lead to phagocyte activation. 
This results in phagocytosis of the respective antigen source and digestion. The 
concept of pattern recognition receptors has remained conserved in the evolutionary 
ladder from C. elegans (Hoffmann, Kafatos et al. 1999; Liberati, Fitzgerald et al. 
2004) up to homo sapiens. The most prominent among them are the so-called Toll 
like receptors (Takeda, Kaisho et al. 2003). The recognised pattern is usually a class 
of molecules that is not present in the respective organism, but is expressed by 
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invading organisms, such as lipopolysaccharide in gram-negative bacteria. With this 
simple non-self recognition, phagocyte activation can take place rapidly.  
In higher organisms, the adaptive immune system developed with antibody 
production and MHC I-restricted cytolysis and inflammatory cytokine production. At 
first, the adaptive immune cells had potent phagocytic abilities (Li, Barreda et al. 
2006) that are, however, lost in higher vertebrates. While the actual phagocytosis is 
performed by granulocytes, macrophages and dendritic cells, it has been shown that 
primed T cells produce inflammatory cytokines upon bacterial challenge that activate 
macrophages. However, for the antibacterial response, the presence of phagocytes 
is a condition sine qua non (Rakhmilevich 1995). 
In human and mouse, two broad classes of specialized phagocytes have been 
described, the granulocyte and the macrophage. In the following section, known facts 
about granulocytes and macrophage immune function are summarized. 
 
3.2 Granulocytes 
In the light microscope, granulocytes are identifiable by their polymorphic nucleus 
and the presence of typical granula in the cytoplasm. Their name is derived from 
Paul Ehrlich, who first described them and the nature of the granula within (Ehrlich 
1900). At the timepoint of their discovery, the staining technique allowed to 
differentiate granula by dye uptake. The mature granulocyte harbors several 
antibacterial agents in two types of granula, the azurophil and specific granula 
(Borregaard and Cowland 1997). Azurophil granula contain the myeloperoxidase that 
is used to produce hydrogen peroxide H2O2. This substance has a strong 
antibacterial effect. Elastase, defensin and lysozyme are also found within these 
granula. Elastase can degrade elastic fibers and outer membrane proteins from 
Shigella and Escherichia coli (Belaaouaj, Kim et al. 2000). Defensin (Ganz 1999) 
peptides are highly active against many bacteria. Lysozyme (Ellison and Giehl 1991) 
is the classic proteolytic enzyme that is also used in lysosomes and in saliva to 
degrade foreign as well as native proteins. So-called specific granula contain 
gelatinase, presumably for dissolving basement membranes (Borregaard and 
Cowland 1997), and the protein lactoferrin of still unknown function. Upon activation 
of the granulocyte, all these mediators can be released in the process of 
degranulation.  
 
 
 7
Granulocytes are short-lived cells that are produced in the bone marrow in quantities 
comparable to erythrocytes upon stimulation of granulopoiesis by the cytokine G-
CSF (Babior 2001). Their half-life, however, is only a tenth of the erythrocyte: About 
2-10 days (Babior 2001). After maturation, at least a part of the granulocytes leaves 
the bone marrow and enters the blood stream (Martin, Burdon et al. 2003). In 
humans, they constitute about 70% of all blood leukocytes, in mice about 10%. From 
there, granulocytes can infiltrate peripheral tissues in a cytokine- and integrin-
dependent process (Parkos, Delp et al. 1991; Broaddus, Boylan et al. 1994; Furie 
and Randolph 1995; Parkos 1997) or re-enter the bone marrow in a CXCR2 and 
CXCR4-dependent process (Martin, Burdon et al. 2003). Only very few granulocytes 
are found in peripheral tissues under normal conditions except in the spleen, where 
aged granulocytes are thought to be cleared from the blood stream by macrophages 
(Suratt, Young et al. 2001). In the mouse, also a small part of granulopoiesis has 
been shown to occur in the spleen (Golde, Faille et al. 1976). When a peripheral 
bacterial infection occurs, a large number of granulocytes quickly accumulates at the 
bacterial lesion beginning a few hours after infection (Mackaness 1962). These 
granulocytes fulfill their anti-bacterial function and are degraded to cellular debris 
(pus) that form the center of the newly formed abscess. In this manner, a large 
number of granulocytes can be consumed. Cellular debris is then cleared by 
infiltrating macrophages. It has been found that administration of LPS as an 
inflammatory stimulus results in heightened granulopoiesis (MacVittie and Walker 
1978; Levitt and Quesenberry 1982). The survival time of a granulocyte after entering 
tissues is largely unclear. One study showed with peripheral blood granulocytes that 
their survival time in vitro can be prolonged by administration of acute phase 
cytokines such as IL-1a, IL-6 and TNF-α (Colotta, Re et al. 1992). Other studies have 
shown that granulocyte survival is shortened when anti-bacterial mechanisms are 
activated such as the NADPH Oxidase enzyme (Lundqvist-Gustafsson and 
Bengtsson 1999). We have investigated this question also to some extent (see 
below).  
When peripheral blood, splenocytes or bone marrow are analysed by FACS 
technology, granulocytes can be easily identified by their light scattering properties 
and size. Apart from morphology, granulocytes can be specifically stained with 
monoclonal antibodies, which we have always done for the experiments in these 
studies. By immunohistochemistry or FACS, the surface antigens Ly6G, which  
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overlaps with the GR-1 antigen, and the activation-induced β2 integrin CD11b are 
usually used for identification of granulocytes in the bone marrow as well as in the 
periphery (Fleming, Fleming et al. 1993).  
Granulocytes have different states of activation (Hallett and Lloyds 1995). In the bone 
marrow, their anti-bacterial mechanisms are usually dormant, which is presumably 
important as great immunopathology can occur when granulocytic enzymes are set 
free inappropriately (Schmitz, Kurrer et al. 2005). One example of a pathological 
granulocyte-dependent immunopathology is Wegener's disease where antibody-
dependent lysis of peripheral granulocytes occurs, leading to inflammation and 
formation of granulomas (van Rossum, Limburg et al. 2005). Several methods have 
been described in the literature that give information about the activation status of 
granulocytes. Upregulation of the β2 integrin CD11b on the surface of granulocytes 
can be measured as an early marker during activation (Kuijpers, Tool et al. 1991) by 
FACS, usually as mean fluorescence intensity. Another indication of activation is the 
NADPH oxidase activity (Benna, Dang et al. 1997). This enzyme is involved in 
production of superoxide (O2-) and is the key player of most antibacterial effector 
functions (Reeves, Lu et al. 2002). Its activity can be measured by oxidation-
activated fluorescent dye like DHR123 (Smith and Weidemann 1993). H2O2, an 
antibacterial agent of lesser importance that is produced by activated 
myeloperoxidase, can also be measured in a similar manner. Degranulation of anti-
bacterial enzymes is measurable by specific ELISA and has been established for β-
lactoferrin. An assay that is less often used nowadays is oxygen consumption by 
activated granulocytes (Proctor 1979).  
In clinical medicine, lack of peripheral or bone marrow granulocytes signifies a high 
risk of bacterial or fungal infections. For experimental induction of agranulocytosis, 
granulocytes can be depleted by administration of monoclonal antibody against 
surface antigens (GR-1) (Czuprynski, Brown et al. 1994). How the depletion works is 
not elucidated, but as few as 25μg of the antibody are sufficient to eliminate >98% of 
granulocytes in the blood, spleen and bone marrow (Tvinnereim, Hamilton et al. 
2004) for at least 3 days (own observation).  
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3.3 Macrophages and Monocytes 
Macrophages are characterized by relatively large sizes of >12μm and a large non-
convoluted nucleus (Wiktor-Jedrzejczak, Ansari et al. 1992). Often, they have a 
foamy pattern in the cytoplasm, which is associated with phagocytic activity. 
Macrophages are found everywhere in the body, and both motile and immotile forms 
exist – however, unlike granulocytes, they are often adapted to the organ 
microarchitecture and have been given specific names depending on their 
localization (Chan, Leenen et al. 1998; Ziegler-Heitbrock 2000). Free and motile 
macrophages are found in the peritoneum and in the blood. On the other hand, fixed 
macrophages are found in solid organs such as the Kupffer cells in the liver, lining 
the capillaries (Pulford and Souhami 1981), red pulp macrophages (Martinez-
Pomares, Hanitsch et al. 2005), marginal zone (Kraal and Janse 1986) and follicular 
tingible body macrophages in the spleen (Mueller, Cremer et al. 2001), alveolar 
macrophages in the lung and so forth. Especially the Kupffer cells have been 
reported to be immotile although they can protrude into lumen of neighbouring 
capillaries with ameboid movements (Motta 1975). It has been reported that 
macrophages can divide in tissues, but they originally arise from the bone marrow 
with a turnover of several weeks after irradiation (Gale, Sparkes et al. 1978). 
Macrophages were first identified by Metchnikoff as having phagocytotic activity 
during infections (Metchnikoff 1905). During bacterial infection with Listeria 
monocytogenes, has been observed that infiltrating mononuclear cells replace 
granulocytes starting from day 3 to 4 (Mackaness 1962). These cells arise from the 
blood (North 1970; Moghimi 2002) or from dividing fixed tissue-resident 
macrophages such as Kupffer cells (North 1969). They have been identified to clear 
debris (Krysko, Denecker et al. 2006), have bactericidal activity (Mackaness 1962); 
(Leist, Heuchel et al. 1988) and present antigens on MHC class II (Janeway 1989).  
During bacterial infection with Listeria monocytogenes, resident macrophages of the 
spleen and liver are the first cells to harbor bacteria (Cousens and Wing 2000). They 
play a crucial role in reducing the bacterial load.  
To deplete macrophages for experiments, it is possible to administer liposomes 
loaded with the agent clodronate (van Rooijen and van Nieuwmegen 1984). These 
liposomes are actively phagocytosed and clodronate causes macrophages to enter 
apoptosis. This method is greatly effective for Kupffer cells and fixed splenic 
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macrophages. After depletion of these macrophages by clodronate, the susceptibility 
to L.m. is greatly increased (Ebe, Hasegawa et al. 1999). 
At least some macrophages arise from infiltrating monocytes. They are characterized 
by a relatively large size with 12-15μm, a large pale and bean-shaped nucleus and 
relatively clear cytoplasm. These cells arise from the bone marrow during 
monocytopoiesis which can be stimulated by administration of M-CSF and GM-CSF 
(Merchav and Wagemaker 1984). Blood monocytes can be measured in FACS by 
the surface antigens CD11b and high expression of the M-CSF receptor CD115 
(Sunderkotter, Nikolic et al. 2004) or high expression of the surface antigen Ly6C 
(Serbina and Pamer 2006), whereas granulocytes express only intermediate 
amounts of Ly6C. Bone marrow monocytes and their precursors have not been 
clearly identified by FACS surface markers, although some have used the same 
surface antigens as in blood. It has been shown that upon inflammatory stimulation of 
the peritoneum, infiltrating macrophages arise from the bone marrow monocytes. In 
contrast to this finding, peritoneal macrophages in the normal state have a slow 
turnover of several weeks (van Furth and Cohn 1968). 
Monocytes have been implicated in phagocytosis of pathogens and debris. During 
Listeria monocytogenes infection of the mouse, at day 3 to 4 infiltration of 
mononuclear cells that are assumed to stem from monocytes are observed at the site 
of bacterial lesions and replace granulocytes (Mackaness 1962). To gain more 
insight in the role of the monocytes in actual pathogen clearance, it would be 
interesting to know whether the abscesses at the transition from granulocytic to 
monocytic infiltration are still bearing a heavy bacterial load or whether only quasi-
sterile abscesses are infiltrated by monocytes for clearance of cellular debris. 
Interestingly, several groups have made the finding that  inflammatory peritoneal 
macrophages cannot effectively clear bacteria in contrast to resident peritoneal 
macrophages (Baker and Campbell 1980; Harrington-Fowler, Henson et al. 1981; 
Sich, Bubel et al. 1987), although their phagocytotic capacity is not impaired.  
Monocytopoiesis has been reported to be sensitive to the cytostatic drug etoposide. 
With this reagent, one could gain information about the role of monocytes during L.m. 
infection. 
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3.4 Listeria monocytogenes 
We have used Listeria monocytogenes infections in mice for our experiments. This 
model infection has been used for over 50 years in immunology and much 
information about the elicited early and adaptive immune responses is available. L.m. 
has originally been described in 1926 as the cause of a lethal disease in a rabbit 
colony in Cambridge, England (Murray 1926). These rabbits were found to form a 
great monocytosis in blood, and therefore the bacterium was named Bacterium 
monocytogenes. A nearly concurrent report from South Africa described a 
grampositive bacterium as the cause of Tiger River Disease, a deadly malady of wild 
gerbils (Pirie 1927). This disease was characterized by a necrotizing hepatic infection 
and was named Listerella hepatolytica in honor of the british surgeon Joseph Lister. 
As the bacterium was later found to be identical, the name was changed to Listeria 
monocytogenes. Its natural habitat was found to be soil, with a predilection to grow in 
dairy products and raw meats from which oral infection results.  
L. monocytogenes was subsequently found to cause human disease in pregnant 
women, leading to septic abortions, and meningitis and sepsis in elderly and 
immunocompromised individuals (Gellin and Broome 1989). 
A large range of mammals have been found to be susceptible to L. monocytogenes, 
among them the mouse. In the tested laboratory strains, the predominant pathology 
found is usually the hepatic infection after 2-6 days (Wilder and Sword 1967). After 
this phase is survived, a later infection of the CNS resulting in meningitis sometimes 
occurs at 7-21 days (Prats, Briones et al. 1992).  
The natural route of infection with L. monocytogenes is the oral ingestion, which 
results in adherence to intestinal epithelial cells by the bacterium. To achieve this, the 
protein internalin A is required, which is expressed at the listerial surface and 
interacts with epithelial cadherin (E-cadherin) at the surface of epithelial cells 
(Gaillard, Berche et al. 1991). Mice have a point-mutation in the E-cadherin 
sequence which renders the described interaction much less efficient than in the 
human intestine, resulting in a relative resistance of mice to oral infection (Lecuit, 
Vandormael-Pournin et al. 2001; Lecuit 2005). After invasion of the epithelial layer, 
bacteria enter the blood stream and are internalized by hepatic and splenic tissue 
macrophages and hepatocytes which offer the hepatocyte growth factor receptor for 
interaction with listerial internalin B (Shen, Naujokas et al. 2000).  
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After phagocytosis, L.m. secretes listeriolysin O, a protein which lyses the 
phagosomal membrane and allows bacteria to escape in the cytosol (Bielecki, 
Youngman et al. 1990). From this compartment, bacteria start to express the actin-
assembly-inducing protein (ActA) at one pole, a bacterial protein that nucleates actin 
(Domann, Wehland et al. 1992; Kocks, Gouin et al. 1992), creating actin-polymers 
that propel the bacteria through the cytoplasm into neighbouring cells. This mode of 
propagation is essential for listerial virulence as knockout variants of the bacterium 
are strongly attenuated (Goossens and Milon 1992).  
Although the natural route of infection is oral, most laboratory studies use the 
intravenous or intraperitoneal route, thereby focusing on the systemic phase of the 
infection and disregarding the mucosal as well as the mucosal-induced systemic 
immune response.  
Early during infection, an effective acute phase response is essential for limiting the 
infection. TNF-α as well as IFN-γ are required, as demonstrated with knockout 
mouse studies (Buchmeier and Schreiber 1985; Havell 1989; Pfeffer, Matsuyama et 
al. 1993). These cytokines are presumably activating tissue macrophages that have 
ingested L.m. to upregulate lysosomal processing and limiting phagosomal escape. 
Other cytokines such as IFN-α have been found to be detrimental for the anti-listerial 
innate immune response (Auerbuch, Brockstedt et al. 2004; Carrero, Calderon et al. 
2004; O'Connell, Saha et al. 2004). Bacteria are destroyed by infiltrating phagocytes, 
among them first the granulocytes (Rakhmilevich 1995) and then later the 
macrophages (Mackaness 1962). The granulocytes reduce an initial inoculum of L.m. 
that reaches mainly the liver by more than 90% within 12 hours (Conlan and North 
1994). It has been shown that the number of bone marrow granulocyte/macrophage 
colony precursors correlates positively with the innate resistance to L.m. (Young and 
Cheers 1986). In the first 3 days, the bacteria are held in check by these two types of 
phagocytes. Later, T cells (Zinkernagel, Blanden et al. 1974) are primed and infiltrate 
the infected organs. Their role is mainly to produce inflammatory cytokines such as 
IFN-γ for activation of phagocyte killing activity (Leist, Heuchel et al. 1988; Leist, 
Meager et al. 1991), as direct lysis of infected cells has not been demonstrated. 
There is a high-titered antibody response against listeria monocytogenes, but it is not 
protective (Miki and Mackaness 1964).  
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3.5 Staphylococcus aureus and Salmonella typhimurium 
As further infection models, we used Staphylococcus aureus and Salmonella 
typhimurium. S. aureus is a grampositive coccus that grows in clumps and is 
considered one of the major human pathogens (Kowalski, Berbari et al. 2005). It has 
a great predilection for causing purulent infections of the bones (osteomyelitis), heart 
valves (endocarditis) and often, localized infection results in sepsis. Unfortunately, 
there are S. aureus strains that have acquired resistance genes to all known 
antibiotics including vancomycin (VRSA) (Chang, Sievert et al. 2003). Although these 
infections can still be treated by elevation of the vancomycin concentration close to 
the threshold of toxicity for the patient in combination with oxacillin, the prognosis is 
that sooner or later, these strains might not be cureable anymore with antibiotics.  
In the mouse, S. aureus has been used as a model infection. It produces septic 
disease early after infection (Verdrengh and Tarkowski 1997). If low inoculation 
dosages are used, chronic purulent infection of the articulations develop. S. aureus 
has been reported to be phagocytosed by granulocytes and macrophages 
(Kowalska, Szydlowska et al. 1987; Kielian, Barry et al. 2001), and with depletion 
studies it has been shown that both cellular subsets are essential, as with L.m. 
(Verdrengh and Tarkowski 1997; Tanaka, Miyazaki et al. 2004). However, T cells 
have not been shown to play a role for clearance of this pathogen.  
Salmonella typhimurium is a gramnegative rod that is present in asymptomatic carrier 
patients (Bhan, Bahl et al. 2005). The infection is acquired by ingestion of 
contaminated foods and results in gastrointestinal symptoms such as diarrhea, 
vomiting, fever and malaise. In the mouse, it is used as oral or i.v. infection and 
results in infection of solid organs (Lin, Wang et al. 1987; Wang, Lin et al. 1988) 
where the bacteria are destroyed within neutrophil granulocytes and macrophages 
(Gellin and Broome 1989). As with L.m., it has been shown that correlations exist 
between granulocyte bactericidal activity and susceptibility of the respective mouse 
strain to Salmonella typhimurium (van Dissel, Stikkelbroeck et al. 1986). 
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3.6 Lymphocytic choriomeningitis virus 
LCMV is an enveloped, single stranded RNA with two segments (Buchmeier 2001). It 
mainly infects macrophages and dendritic cells, but can be pleiotropic as soon as 
infection is established. LCMV induces a strong response by innate immunity that is 
characterized by high secretion of IFN I, produced mainly by dendritic cells (Dalod, 
Salazar-Mather et al. 2002). After day 4, it induces a cytotoxic CD8+ T cell response 
that clears the virus. We have used LCMV mainly as an inducer of IFN I. 
 
With these model infections, we have addressed several questions which are 
detailed in the introductions of the different chapters. In the following studies, we 
have reproduced some classical findings and found an important role for the kinetics 
of granulocytes during the whole period of L.m. infection. We have investigated the 
course of infection when granulocytes are systemically activated by either virus-
induced type I interferon, or by ligation of toll like receptor 2 with Pam2Cys, 
simulating a grampositive sepsis. In another approach, we stimulated the innate 
immune system with lipopolysaccharide and detected a prolonged reactivity that 
resulted in heightened anti-bacterial resistance. 
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4. Aim of the presented research work 
 
4.1 General considerations 
The bone marrow as the origin of circulating granulocytes has long been neglected in 
analysis during infections. A striking lack of reports of the interplay between GRC 
infiltration of bacterial lesions and GRC reserve in the bone marrow exists. Because 
the number of GRC present in the blood is of highest medical relevance in all 
immunocompromised patients, we have started our experiments in analysing this 
interplay during bacterial and viral infections.  
 
4.2 Bone marrow granulocyte reserve during bacterial infections 
In the course of our experiments, we found that the number of bone marrow 
granulocyte is affected during bacterial infections. We therefore strove to investigate 
the relation between bacterial load and granulocyte reserve. 
 
4.3 Bone marrow granulocyte reserve during viral infections 
When the LCMV infection was analysed for influence on the granulocyte reserve, 
increased apoptosis and lowered numbers of granulocytes was found in a time 
window early after the infection. In further experiments, it was then analysed whether 
this influenced the susceptibility to bacterial super-infection. 
 
4.4 Bone marrow granulocyte reserve after systemic TLR2 ligation 
By administration of TLR2 ligands, it was found that granulocytes reacted 
immediately with great activation and heightened cell death in the bone marrow. We 
used this effect to investigate the influence of a sudden increase of circulating 
bacterial products on the resistance to a non-lethal bacterial infection. 
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4.5 Prolonged innate reactivity  
When later timepoints after administration of TLR ligands, bacterial or viral infections 
were analysed, a consistent elevation of bone marrow granulocytes was found. 
Further we showed that after a sudden reduction of their number, bone marrow 
granulocytes accumulate in elevated numbers for a certain time. We then analysed 
whether this corresponded to a simple form of "memory" that would enable the 
preexposed mouse to react more strongly to a renewed stimulus. 
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5. Exhaustion of bone marrow granulocyte numbers during 
uncontrolled bacterial infections 
 
5.1 Abstract 
Bacterial infections capable of infesting tissues require phagocytes for clearance. We 
have used the model system Listeria monocytogenes to study phagocyte responses 
to bacterial infection. We observed that during the whole period of active infection, 
granulocytes were recruited to bacterial lesions. Granulocyte numbers in the bone 
marrow were reduced accordingly, correlating with the number of bacteria inoculated. 
Blood granulocyte numbers increased but reached a plateau independent of the 
inoculum. We further observed that during overwhelming infection, all bone marrow 
granulocytes could be depleted until supply of fresh granulocytes to abscesses 
ended and insufficient bacterial containment occurred. This led to sepsis and death. 
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5.2 Introduction 
Granulocytes are the most short-lived cells of the body. Their main function is to 
actively combat invading pathogens by phagocytosis, oxidative agents and 
enzymatic digestion. Granulocytes have their origin in the bone marrow where 
granulopoiesis occurs (Babior 2001). This is a process of development from stem 
cells that takes about 14 days. It is thought that it can be shortened upon heightened 
demand of granulocytes in the periphery. After maturation, granulocytes are kept in 
the bone marrow for a few days until release in to the blood stream. Only a small part 
of the available granulocytes are circulating at a time, about 1 million in the blood of 
the mouse compared to 64 million granulocytes in the whole bone marrow (Babior 
2001; Blankenberg, Tait et al. 2001). Circulation time is measured in hours and ends 
in marginalization and diapedesis through capillary walls (Babior 2001). After 
entering peripheral tissues, granulocytes use chemotaxis to approach inflammatory 
targets (Godaly, Bergsten et al. 2001; Fierer, Swancutt et al. 2002). It is known from 
in vitro experiments that they can survive up to 3 days when stimulated to some 
extent with inflammatory acute phase cytokines such as IL-6 or IL-1 (Colotta, Re et 
al. 1992). However, after full activation, the respiratory burst mechanism is 
upregulated. Great O2 consumption is found in activated granulocytes which produce 
H2O2 and O2- that are used to kill pathogens. This induced oxidative environment is 
also harmful to the granulocyte which undergoes apoptosis after dispensing these 
substances (Watson, Redmond et al. 1996; Yamamoto, Taniuchi et al. 2002; Zhang, 
Hirahashi et al. 2003). The substance pus that is found in many places of granulocyte 
activation is formed primarily of dead granulocytes, cellular detritus and bacteria. Pus 
is later cleared by macrophages and the normal tissue architecture is restored (Hart, 
Dougherty et al. 1997; Blankenberg, Tait et al. 2001).  
Upon inflammatory stimuli, granulocyte numbers in peripheral blood can rise rapidly. 
However, it has been observed that during overwhelming sepsis with organ 
dysfunction and blood pressure insufficiency, granulocyte numbers are either very 
high or very low. Both >12000 / ul and <4000 / ul leukocytes in peripheral blood have 
been shown to contribute to the SIRS syndrome that carries a poor prognosis for the 
patient (Muckart and Bhagwanjee 1997). Granulocyte release from the bone marrow 
is known to depend on inflammatory stimuli (Burdon, Martin et al. 2005).  
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We have asked whether increased bacterial numbers also results in heightened 
granulocyte release from the bone marrow, and whether this would be reflected in 
blood granulocyte numbers as a transitory state.  
As it is as yet unclear if and to what extent granulocyte activation is needed for 
release from the bone marrow, we measured CD11b upregulation in the bone 
marrow as a marker for activation.  
Granulocyte activation is a two-edged sword and can lead to enhanced survival 
(Colotta, Re et al. 1992) as well as apoptosis (Zhang, Hirahashi et al. 2003). 
Therefore, we also measured induction of granulocyte apoptosis in the bone marrow. 
Further, we asked whether the G-CSF response after emigration of granulocytes 
from the bone marrow corresponds to the required supply. This question is of interest 
as administration of recombinant G-CSF has been shown to be beneficial in sepsis, 
implying insufficient production of G-CSF during bacterial infection.  
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5.3 Material and Methods: 
Mice 
Specific pathogen free (SPF) laboratory mice were from the Institute of 
Labortierkunde of the veterinary facility of the University of Zurich. Experiments were 
performed according to Swiss veterinary law and institutional guidelines. C57BL/6 
mice were used. 
Infections 
Listeria monocytogenes (L.m.) strain 10403S grown overnight in Brain Heart infusion 
broth, washed two times in PBS and injected i.v. in 200 ul.  
Bacterial titer  
Bacterial titers were determined in homogenized halfs of spleen, the left lobe of the 
liver, 100ul of flushed bone marrow or 50ul of peripheral blood in PBS with serial 
dilutions plated on brain heart infusion or blood agar plates.  
Bone marrow aspirates and culture  
Bone marrow cells were flushed with PBS from the femur and were stained for FACS 
analysis or cultured in RPMI with 10% FCS.  
FACS and antibodies 
Anti-Ly6G, GR1, CD11b, Annexin V and 7-Amino-Actinomycin-D (7-AAD) were 
obtained from BD, Basel. Cells expressing Ly6G / GR1 and CD11b are termed 
“GRC”. FSC/SSC gates were used to exclude debris. A fixed number of fluroescent 
APC beads were used to quantify cell number per sample volume.  
Histology 
Histological samples were snap-frozen in Hanks medium and stained with an anti-
L.m. rabbit serum (a gift from Prof J. Bille, Lausanne), Gr-1 (Pharmingen) or F4/80 
(BM8, BMA) antibodies. Staining was developed using a goat anti-rat antibody 
(Caltag Laboratories) or goat anti-rabbit (Jackson Immuno Research) and an alkaline 
phosphatase-coupled donkey anti-goat antibody (Jackson Immuno Research) with 
naphthol AS-BI (6-bromo-2-hydroxy-3-naphtholic acid 2-methoxy anilide) phosphate 
and new fuchsin as a substrate. The presence of alkaline phosphatase activity 
yielded a red reaction product. The sections were counterstained with hemalum. 
Determination of cytokine production 
G-CSF was measured with an ELISA from R&D (Minneapolis, USA). 
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5.4 Results 
To determine peripheral blood granulocyte responses to a low dose (1/10 LD50) 
infection with L.m., C57BL/6 mice were infected with 103 colony forming units (cfu) 
L.m. intravenously and granulocyte numbers were followed in the blood over time by 
FACS staining with surface markers Ly6G and CD11b. We found that granulocytes 
increased until day 5 in the blood up to 2000 /  μl, then dropped to normal levels 
again until day 9 (Fig. 1a). During in- and decrease of granulocyte numbers, great 
variability was found between different animals. To determine whether this would 
correspond to the number of granulocytes in the bone marrow, eluates from the 
femur were counted for Ly6G+CD11b+ cells at the different timepoints. A numerical 
decrease of Ly6G+CD11b+ cells was measured during the L.m. infection of about 
60% that was followed by a strong increase of granulocyte numbers during later days 
of the infection (Fig. 1a). Ly6G-negative CD11b+ monocytic cells (Lagasse and 
Weissman 1996; Dahl, Walsh et al. 2003) did not show a similar reduction. All mice 
survived the infection at least 30 days (Fig. 1c). 
We then asked whether granulocyte reduction in the bone marrow correlated with the 
bacterial load at the different timepoints. Therefore, organs were harvested at the 
different timepoints, homogenized and plated on agar (Fig. 1b). Bacterial titers in 
organs increased until day 3 up to 5 x 106 cfu per organ, then dropped again below 
the detection limit at day 9. The numerical reduction of granulocytes in the bone 
marrow correlated directly with the bacterial load in spleen and liver (p<0.0001) 
(Supp. Fig. 1). To determine whether granulocyte consumption was responded to by 
increased stimulation of granulopoiesis, G-CSF was measured in serum. Levels of G-
CSF were highest at day 2 and then decreased to undetectable levels until day 7 
(Fig. 1d).  
Next, it was investigated whether the decrease of granulocytes in the bone marrow 
was paralleled with infiltation in infected tissues. At the different timepoints, 
immunohistology was performed on the liver and spleen with the marker GR-1 
(Ly6G/C), and macrophages with the pan-macrophage specific marker F4/80. In the 
liver, no granulocytes are found in the naïve state. After infection, granulocytic 
infiltrates were visible starting from day 2 of the infection, forming small abscesses 
around bacterial lesions, with maximal granulocytic abscesses at day 4. F4/80+ cells 
infiltrated abscesses at day 3-4 and starting from day 5-7 replaced granulocytes.  
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However, granulocytes were present during the whole period of the infection at the 
bacterial lesion (Fig 2a). We found that granulocytes were present already in the 
naïve state in the red pulp of the spleen. Beginning at day 1 after infection, the 
number of granulocytes increased and started to concentrate around bacterial 
lesions. The strongest infiltates were found at day 4 where dense clumps of 
granulocytes filled about a fifth of the splenic parenchyma. Granulocyte aggregates 
then started to thin out but persisted around regions of bacterial presence until day 9, 
when no more bacteria were measurable with titration of the organ homogenate. 
Macrophages were present in great numbers already in the naïve state and did not 
visibly change. However, lymphoid follicles were strongly decreased in size at day 5 
(Fig. 2b). We also stained for Listeria monocytogenes bacteria by polyclonal 
antibody, but could not demonstrate bacteria immunochemically during the infection 
with 103 cfu L.m. (Fig. 2a, b). 
To analyse the immune response in a situation that could not be easily contained by 
the immune system, 105 cfu L.m. were used for infection. C57BL/6 mice showed a 
rapid linear decrease of more than 50% of the original granulocyte number at 24 
hours in the bone marrow (Fig. 1e), while at 48 hours, only about 10% of the original 
amount of granulocytes was left in the bone marrow. The Ly6G-negative CD11b+ 
cells that have been shown to be of the monocytic lines did not decrease during the 
infection, suggesting that the observed phenomenon was specific for granulocytes 
(Fig. 1e). Blood granulocytes increased until 24 hours p.inf., then were decreased 
again at 48 hours p.inf. (Fig. 1e). Interestingly, and contrary to expectation, 
granulocytes never reached a higher level in the blood than during the 103 cfu 
infection. The bone marrow granulocyte depletion was accompagnied by a strong 
increase in G-CSF in serum (Fig. 1d). Determination of listerial titers in the spleen 
and liver showed a rapid increase in titers (Fig. 1f) until day 3 when animals showed 
clinical signs of disease and were sacrificed. At this timepoint, animals also 
harboured bacteria in the bone marrow (Fig. 1f). When a linear regression was 
calculated, we found that the elevation of bacterial titers could significantly predict a 
lower bone marrow granulocyte number (Supp. Fig. 1).  
Histological analysis showed dense infiltrates of granulocytes in both liver and spleen 
(Fig. 4a, b) as early as day 1. At day 3, abscesses contained dead granulocytes in 
the center, but at the active edge of the abscesses, no viable granulocytes were 
present.  
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This corresponded to propagation of L.m. in hepatocytes at the edge of these 
insufficient abscesses, visible by strongly stained hepatocytes filled with bacteria. 
Therefore, exhaustion of bone marrow granulocytes correlated with insufficient 
bacterial containment in abscesses. In the spleen, the granulocyte infiltrations also 
lost their cellular integrity at day 3, although no clear abscesses or listerial 
propagation could be discerned.  
To determine whether granulocytes were activated in the bone marrow and blood by 
the infection, we measured CD11b expression on granulocytes, which has been 
repeatedly shown to be an activation marker (Kuijpers, Tool et al. 1991). Both inocula 
led to granulocyte activation in the bone marrow and blood (Fig. 3a,b). The mice that 
had been infected with 103 cfu L.m. showed increased activation in both 
compartments for several days during the active infection, then went back to the level 
of the naïve state. In the group with 105 cfu L.m., granulocyte activation showed a 
linear increase during the infection with the highest value at the time of clinical 
disease. Interestingly, this was not accompagnied by heightened bone marrow 
macrophage (CD11b+Ly6G-) activation. There was no significant difference regarding 
granulocyte CD11b upregulation between the two inocula. However, when the 
percentage of apoptotic granulocytes was examined at the different timepoints, 
inoculation with 105 cfu L.m. led to >50% apoptotic bone marrow granulocytes 
already at day 2 and >70% at day 3 (Fig. 3c,d). Infection with 103 L.m. instead 
induced granulocyte apoptosis not more than 12%. In the blood, almost no apoptotic 
granulocytes were measurable at all times (not shown), possibly due to rapid 
sequestration by the spleen. Taken together, during L.m. infection, activation was 
detectable in both blood and bone marrow granulocytes. After inoculation of a high 
dose of L.m., exhaustion of bone marrow granulocytes was observed, correlating 
with insufficient clearance and reduction of granulocytic infiltrates in infected organs.  
 
 
 30
5.5 Discussion 
Listeria monocytogenes infection resulted in recruitment of granulocytes to the blood 
stream and infiltration in spleen and liver. Granulocyte emigration from the bone 
marrow and infiltration correlated with bacterial load in target organs. G-CSF 
secretion correlated inversely with the granulocyte reserve in the bone marrow. 
Activation of granulocytes in the bone marrow and blood was independent of 
bacterial load in the organs. However, apoptosis induction was found to a strong 
extent in the bone marrow of high dose challenged animals.  
By administrating an overwhelming dose of L.m., we could observe that without 
exception, as soon as the mouse started showing symptoms of uncontrolled bacterial 
proliferation and clinical disease, the bone marrow granulocyte reserve was deprived 
of live granulocytes. Likewise, the bone marrow granulocyte reserve was never 
depleted when the infection was not life-threatening. When granulocytes were 
depleted during an infection with 103 L.m. with monoclonal antibody NimpR14, 
bacteria started uncontrolled growth immediately (not shown, see third chapter). 
Granulocytes have also been found to be essential for containment of L.m. during 
primary and secondary infection (Rakhmilevich 1995). In addition, it has been shown 
that tissue macrophages are also necessary for overcoming the L.m. infection 
(Samsom, Annema et al. 1997). It is less clear what role monocytes have, and no 
studies with selective monocyte depletion have been performed to date. When in our 
study, histology of the 105 cfu L.m. infection was investigated for F4/80+ cells, we 
have found only few hepatic and splenic abscess-infiltrating macrophages until day 3 
(Fig. 4a). We therefore hesitate to attribute an important role to infiltrating 
macrophages in failed survival of this high dose of listeria during the days 3. Instead, 
failed containment of L.m. seems to be at the level of granulocyte insufficiency.  
We observed that almost all granulocytes in the bone marrow were used to 
counteract a peripheral bacterial infection. Furthermore, in the naïve, unprimed state, 
granulopoiesis was not quick enough to produce enough granulocytes to overwhelm 
a high number of bacteria. If granulopoiesis were induced by prior G-CSF treatment 
or inflammatory stimuli, the number of granulocytes produced in emergency 
situations could be much higher (Noursadeghi, Bickerstaff et al. 2002). This could 
also be directly correlated to survival. Clinical studies have been performed with GM-
CSF treatments or direct granulocyte transfusions. Further, avoiding 
granulocytopenia during infections is also important during antibiotic therapy as 
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elevated concentrations of of antibiotics are necessary during granulocytopenia (van 
der Voet, Mattie et al. 1984).  
There have been numerous studies that have used granulocyte transfusions in 
neutropenic immunosuppressed patients, or in septic patients with neutropenia. 
Unfortunately, most of these studies showed mixed results. A reason for this could be 
that transfusion of peripheral blood granulocytes might result in granulocyte 
populations that are of very limited half-life (4-8 hours as published and 
corresponding to our own observation, not shown). In addition, peripheral 
granulocytes probably home much less to the bone marrow when inflammation is 
already present (Lovas, Knudsen et al. 1996). However, with new in vitro culture 
techniques, it might be possible to greatly expand bone marrow granulocytes at more 
immature states. These have been shown to home to the bone marrow and have 
repopulation potential (Szilvassy, Meyerrose et al. 2001) and could therefore be of 
much greater value in generating an effective granulocyte reserve that can protect 
immunosuppressed patients from bacterial infections.  
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5.7 Figure legends: 
Figure 1: Infection with 103 or 105 cfu L.m. 
a) Ly6G+CD11b+ (Granulocytes) and CD11b+Ly6G- (Macrophages) cells in BM 
and Ly6G+CD11b+ in blood at the respective days after low-dose L.m. 
infection (103 cfu) (n=3-4 per time point, mean +/- SEM, one of two 
experiments with similar outcome)  
b) L.m. titers in spleen, liver, BM (cfu/femur) and blood (cfu/μl) at the respective 
timepoints (n=4 per timepoint, mean +/- SEM, one of two experiments with 
similar outcome)  
c) Survival of WT mice after infection with low-dose (103 cfu) or high-dose (105 
cfu) L.m. i.v. (n=5-10 per group)  
d) Serum concentration of G-CSF after infection low-dose (103 cfu) or high-dose 
(105 cfu) L.m. i.v. (n=3-4 per timepoint, mean +/- SEM)  
e) Ly6G+CD11b+ (Granulocytes) and CD11b+Ly6G- (Macrophages) cells in BM 
and Ly6G+CD11b+ in blood at the respective days after infection with 105 cfu 
L.m. (n=3-4 per timepoint, mean +/- SEM, one of two experiments with similar 
outcome)  
f) Bacterial titers in spleen, liver, BM (cfu/femur) and blood (cfu/μl) at the 
respective timepoints (n=4 per timepoint, mean +/- SEM, one of two 
experiments with similar outcome) 
 
Figure 2: Histology timecourse of liver during infection with 103 cfu L.m. 
a) Livers or  b) spleens taken at the respective timepoints were stained 
immunohistochemically for presence of GR-1+ or F4/80+ cells and for L.m. 
bacteria.  
 
Figure 3: Activation and apoptosis during infection with 103 or 105 cfu L.m. 
b) Mean fluorescence intensity of CD11b on the surface of Ly6G+CD11b+ (GRC) 
and CD11b+Ly6G- (Macrophages) cells in BM and blood after infection with 
103 cfu L.m. (n=3-4, mean +/- SEM, one of two experiments with similar 
outcome)  
c) Mean fluorescence intensity of CD11b on the surface of Ly6G+CD11b+ (GRC) 
and CD11b+Ly6G- (Macrophages) cells in BM and blood after infection with 
105 cfu L.m. (n=3-4, mean +/- SEM, one of two experiments with similar 
outcome)  
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d) Percentage of Annexin V+ GRC, macrophages and Ly6G-CD11b- cells (Non-
phagocytes) in BM after infection with 103 cfu L.m. (n=3-4, mean +/- SEM, one 
of two experiments with similar outcome)  
e) Percentage of Annexin V+ GRC, macrophages and Ly6G-CD11b- cells (Non-
phagocytes) in BM after infection with 105 cfu L.m. (n=3-4, mean +/- SEM, one 
of two experiments with similar outcome) 
 
Figure 4: Histology timecourse of liver during infection with 105 cfu L.m. 
a) Livers and b) spleens taken at the respective timepoints were stained 
immunohistochemically for presence of GR-1+ or F4/80+ cells and for L.m. 
bacteria. 
 
Supplementary Figure 1: Correlation between bacterial load and BM Granulocytes in 
low and high dose L.m. infection 
a) Correlation between the mean of BM granulocytes at the respective days and 
bacterial titers in liver and spleen after infection with 103 cfu L.m. 
b) Correlation between the mean of BM granulocytes at the respective days and 
bacterial titers in liver and spleen after infection with 105 cfu L.m. 
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6. Increased susceptibility to bacterial super-infection as a 
consequence of innate antiviral responses 
 
6.1 Abstract  
The reason why severe localised or systemic virus infections enhance and aggravate 
bacterial super-infection is poorly understood. Here we show that virus-induced 
interferon type I caused apoptosis in bone marrow granulocytes, drastically reduced 
granulocyte infiltrates at the site of bacterial super-infection and caused up to 1000-
fold higher bacterial titers in solid organs with decreased host survival. The finding 
that the innate anti-viral immune response reduces the anti-bacterial granulocyte 
defense offers an explanation of enhanced susceptibility to bacterial super-infection 
during viral disease.  
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6.2 Introduction 
Better mechanistical insight into the process of facilitated bacterial super-infection 
during virus infection is needed since it is responsible for many of the 200’000 annual 
cases of life-endangering sepsis in the USA alone (Beadling and Slifka 2004). 
Although several local-acting mechanisms have been proposed (Bakaletz 1995; 
Black 2003; McCullers and Bartmess 2003; Okamoto, Kawabata et al. 2003), an 
explanation for generalized enhanced susceptibility to super-infection is still lacking. 
To address this, we have modelled a systemic bacterial super-infection during virus 
infection by combining well-studied model infections in mice. Lymphocytic 
choriomeningitis virus (LCMV) is a non-cytopathic RNA virus that rapidly spreads 
systemically and strongly induces type I interferon (IFN I) (Malmgaard, Salazar-
Mather et al. 2002). Listeria monocytogenes (L.m.) and Staphylococcus aureus (S. 
aureus) are gram-positive bacteria that cause purulent infections. Both pathogens 
induce strong innate immune responses and attract granulocytes (Babior 2001) and 
subsequently T cell dependent macrophages whose role is to clear the bacteria by 
phagocytosis (Ebe, Hasegawa et al. 1999; Pamer 2004; Foster 2005). During 
agranulocytosis by cytotoxic drugs, irradiation or administration of monoclonal 
antibodies, hosts are rendered much more susceptible to bacterial infections (Rogers 
and Unanue 1993; Czuprynski, Brown et al. 1994; Conlan 1997). Here we show that 
during virus infection IFN I has an early severe granulotoxic effect that drastically 
increases susceptibility to bacterial super-infection. 
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6.3 Material and Methods: 
 
Mice 
Specific pathogen free (SPF) laboratory mice were from the institute of 
Labortierkunde of the veterinary facility of the University of Zurich. Experiments were 
performed according to Swiss veterinary law and institutional guidelines. C57BL/6 
mice, IFN I receptor (IFNAR) knockout mice and relevant controls on 129/SvEv 
background were used. 
Infections 
Listeria monocytogenes (L.m.) strain 10403S grown overnight in Brain Heart infusion 
broth, washed two times in PBS and injected i.v. in 200 μl. Lymphocytic 
choriomengitis virus (LCMV) strain WE (from F. Lehmann-Grube, Heinrich Pette 
Institute, Germany) was grown on BHK cells and 2x106 pfu were injected i.v. in 200 
μl. Staphylococcus aureus Newman ATCC 25904 (S. aureus) was grown in Brain 
Heart Infusion medium, washed two times and frozen down. Thawed aliquots were 
washed and then used for infection was given i.v. in 200 μl at a dose of 2x107 cfu per 
mouse. Salmonella typhimurium was grown in LB medium, and given i.v. in 200 μl at 
a dose of 1.2*104 per mouse. 
Bacterial titer  
Bacterial titers were determined in homogenized halfs of spleen, the left lobe of the 
liver, the left lung or the whole left kidney in PBS with serial dilutions plated on brain 
heart infusion or blood agar plates.  
Bone marrow aspirates and culture  
Bone marrow cells were flushed with PBS from the femur and were stained for FACS 
analysis or cultured in RPMI with 10% FCS.  
FACS and antibodies 
Anti-Ly6G, GR1, CD11b, Annexin V and 7-Amino-Actinomycin-D (7-AAD) were 
obtained from BD, Basel. Cells expressing Ly6G / GR1 and CD11b are termed 
“GRC”. FSC/SSC gates were used to exclude debris in organ homogenates and 
peritoneal washings. Dihydrorhodamine 123 (DHR, Sigma) was used for measuring 
NADPH oxidase activity by measuring cellular fluorescence in FL1 channel (emission 
534nm). A fixed number of fluroescent APC beads were used to quantify cell number 
per sample volume. Anti-GR1 (NimpR14) hybridoma was a generous gift from Dr 
Tacchini-Cottier, WHO, Geneva. 
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Histology 
Histological samples were snap-frozen in Hanks medium and stained with an anti-
L.m. rabbit serum (a gift from Prof J. Bille, Lausanne), Gr-1 (Pharmingen) or F4/80 
(BM8, BMA) antibodies. Staining was developed using a goat anti-rat antibody 
(Caltag Laboratories) or goat anti-rabbit (Jackson Immuno Research) and an alkaline 
phosphatase-coupled donkey anti-goat antibody (Jackson Immuno Research) with 
naphthol AS-BI (6-bromo-2-hydroxy-3-naphtholic acid 2-methoxy anilide) phosphate 
and new fuchsin as a substrate. The presence of alkaline phosphatase activity 
yielded a red reaction product. The sections were counterstained with hemalum. 
Determination of cytokine production 
ELISA assays for murine IFN-α and IFN-β by PBL Biomedical Laboratories 
(Piscataway, NJ, USA) were used on sera and culture supernatants. G-CSF was 
measured with an ELISA from R&D (Minneapolis, USA). 
Statistical analysis 
In all figures, unpaired two-sided t test or one-way analysis of variance (ANOVA) was 
used. P values above 0.05 were not considered significant. * for p<0.05, ** for 
p<0.01, *** for p<0.001. 
End notes:  
A.A. Navarini and M. Recher have contributed equally to this work. 
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6.4 Results 
When C57BL/6 mice were infected with LCMV-WE 2 days before super-infection with 
L.m. (Fig. 1a), they exhibited up to 1000-fold higher bacterial titers in liver and spleen 
at day 3 of the super-infection compared to control mice without LCMV infection (Fig. 
1b) as well as drastically decreased survival (Fig. 1c). This early phase of L.m. 
infection is largely controlled by innate resistance through granulocytes (Rogers and 
Unanue 1993; Czuprynski, Brown et al. 1994; Conlan 1999; Seiler, Aichele et al. 
2000; Wing and Gregory 2002), whereas after day 3, T cell-mediated control is 
crucial (Lane and Unanue 1972). Failure to control bacterial super-infection was not 
simply a consequence of virus replication, since bacterial elimination was even 
enhanced at day 5 after LCMV infection when virus titers were comparable or even 
higher than at day 3 (Supplementary Fig. 1a,b and data not shown). Together with 
existing evidence, this suggested that the underlying mechanism reflected a transient 
change of the early host anti-bacterial response. This finding was akin to the 
observation of an unexplained susceptibility to bacterial super-infection in the lung in 
the timeframe of day 2-5 after influenza A virus infection (Okamoto, Kawabata et al. 
2003). In humans, bacterial super-infections become clinically apparent variably but 
usually starting as soon as 3-5 days after the onset of virus-induced clinical 
symptoms (Beadling and Slifka 2004). The recognized major role of granulocytes in 
controlling early L.m. infection (Rogers and Unanue 1993; Czuprynski, Brown et al. 
1994; Conlan 1997; Pamer 2004) was confirmed by depletion of granulocytes at day 
1 after bacterial infection by administration of an anti-GR1 antibody (Fig. 1b). Thus, 
increased susceptibility due to viral pre-infection could be mimicked by physical 
absence of granulocytes. To determine whether granulocytes were indeed involved 
and affected, bone marrow granulocytes were quantified by FACS three days after 
super-infection. Granulocytes were strongly reduced in LCMV pre-infected mice 
compared to control mice up to day 5 (Fig. 1d).  
Next, granulocyte kinetics after LCMV infection in absence of bacterial super-
infection were measured. Granulocyte numbers in bone marrow of C57BL/6 mice 
were analysed at different time-points after LCMV-WE infection (Fig. 1e). After an 
initial small increase, granulocyte numbers dropped to about 30% of the original 
number from 2-5 days after LCMV infection. This correlated with induction of 
granulocyte apoptosis (Fig. 1e). Thereafter, granulocyte numbers normalized until 
day 9. In a study analyzing influenza infection in monkeys as well as in another with 
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human patients, a reduction of blood polymorphonuclear leukocytes has been 
reported at day 3 after admission to the hospital (Berendt and Hall 1977; Lewis, 
Gilbert et al. 1986). The fate of other cell types during LCMV infection was also 
investigated by immunohistology. In spleen, macrophages increased somewhat at 
day 5 after LCMV infection, while liver macrophages remained unchanged during the 
entire period analysed (Supplementary Fig. 2a). NK cell numbers in the bone marrow 
stayed at low levels until day 5, then strongly increased in numbers (Supplementary 
Fig. 2b). T cell numbers were low until day 7, when the expected LCMV-associated T 
cell proliferation could be demonstrated (Supplementary Fig. 2b). B220+ B cells 
decreased (Borrow, Hou et al. 2005) comparably to granulocytes early during LCMV 
infection but did not recover to original numbers during the 15 days studied, reflecting 
the known immunopathological destruction of lymphoid tissue (Moskophidis, Pircher 
et al. 1992) (Supplementary Fig. 2b). Thus, only granulocyte kinetics correlated with 
the relatively short time period of virus-induced failure to control bacterial super-
infection. 
To determine whether virus-induced granulocytopenia might be associated with 
excessive activation, expression of the β2-integrin CD11b on the surface of bone 
marrow granulocytes after virus infection was measured (Fig. 2a). Granulocytes were 
activated by 24 hours after LCMV infection. At day 7 after virus infection, CD11b 
surface expression normalized. Both phagocytosis and superoxide production by 
bone marrow granulocytes was increased in LCMV-infected compared to untreated 
animals (Fig. 2b,c). To determine whether the observed state of pre-activation 
resulted in heightened cell damage upon contact with live bacteria, we measured the 
percentage of 7-Amino-Actinomycin-D+ granulocytes after 1 hour of co-incubation 
with L.m. Dead granulocytes were increased 2.5 fold after virus infection and 
bacterial challenge vs. untreated, while both virus and bacterial infection alone also 
induced granulocyte damage (1.7 and 1.9 fold of untreated) (Fig. 2d and Fig. 1e). 
Our results so far demonstrated that granulocyte activation and induction of 
apoptosis correlated with a failure to effectively counter bacterial super-infection. 
Mechanistically, the lowered granulocyte reservoir in the bone marrow could limit the 
effective granulocyte homing to the site of bacterial super-infection. C57BL/6 mice 
were therefore challenged with a high dose of L.m. at day 3 of LCMV infection. 
Numbers of infiltrating granulocytes were analysed in spleen and liver four hours 
after L.m. injection. Virus-infected animals showed three-fold less granulocytes in  
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both organs (Fig. 2e). In an additional experiment, thioglycolate, known to provoke 
rapid recruitment of granulocytes into the peritoneum (Baron and Proctor 1982), was 
injected i.p. at day 3 of LCMV infection. Four hours later, LCMV-infected mice 
demonstrated 50% less granulocytes in the peritoneal cavity than control animals 
(Fig. 2f).  
The observed bone marrow granulocytopenia could reflect several mechanisms, 
reduction by apoptosis in the bone marrow and/or emigration and accumulation in the 
periphery. The third possibility, i.e. reduced induction of granulopoiesis, was an 
unlikely explanation as strongly elevated expression of granulocyte colony 
stimulating factor (G-CSF) at the time of granulocyte depletion was measured (Fig. 
1e). Assessment of apoptosis on bone marrow cell suspensions after LCMV infection 
revealed increased granulocyte apoptosis starting from day 2 after infection. This 
inversely correlated with the number of granulocytes present in the bone marrow 
(Fig. 1e). Induction of apoptosis was specific for granulocytes, as non-granulocytic 
bone marrow cells did not show elevated apoptosis at day 3, the time-point of 
maximal granulocyte apoptosis (Supplementary Fig. 2c). We then tested whether 
granulocytes showed enhanced emigration and accumulation in the periphery by 
quantifying granulocytes in blood, spleen and liver by FACS and immunohistology 
(Supplementary Fig. 2e). Blood granulocyte numbers dropped early during virus 
infection, then stayed low and increased only after day 5 (Supplementary Fig. 2d). In 
spleen, detectable granulocytes approximately doubled by day 2 after LCMV 
infection, corresponding to about two million granulocytes per spleen. As we 
observed a loss of approximately 70% of the total 65 million granulocytes (Babior 
2001) in the entire bone marrow, enhanced migration could not explain bone marrow 
granulocyte loss. Granulocyte numbers remained unchanged in the liver 
(Supplementary Fig. 2e). Taken together, activation-associated granulocyte death 
following virus infection was the main mechanism for the observed bone marrow 
granulocytopenia.  
Next, we tested whether granulocyte apoptosis was a consequence of antiviral 
mediators produced early during LCMV infection. Type I interferon (IFN I) production 
after LCMV infection peaked at day 1 after infection and inversely predicted bone 
marrow granulocyte numbers (Fig. 3a). To demonstrate causal relationship, IFN I 
receptor knockout mice (IFNAR-/-) were infected with LCMV and bone marrow 
granulocyte numbers were measured at day 3 when T cell responses had not been  
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mounted yet and viral titers were equal in both strains (Binder, Fehr et al. 1997). 
IFNAR-/- did not exhibit a reduction of granulocytes in the bone marrow whereas wild-
type mice had 12-fold reduced granulocyte numbers compared to untreated animals 
(Fig. 3b). Furthermore, IFNAR-/- showed no increase in granulocyte apoptosis 
following LCMV infection in vivo (Fig. 3c). Correspondingly, bone marrow cell 
suspensions of naïve wild-type but not IFNAR-/- treated in vitro with recombinant type 
I interferon for 72 hours revealed a dose-dependent induction of granulocyte 
apoptosis (Fig. 3d).  
To confirm the crucial role of virus-induced IFN I in impairing granulocyte-mediated 
control of bacterial infection, IFNAR-/- and wild-type mice were LCMV-infected and 
two days later super-infected with L.m. Another two days later, wildtype mice 
displayed 1000-fold higher bacterial titers than IFNAR-/- in spleen, and about 20-fold 
higher titers in liver (Fig. 4a). This correlated with drastically lower granulocyte 
infiltration in the periphery in LCMV infected wildtype mice (Fig. 4c,d and lower 
magnifications in supplementary Fig. 3). The virus-induced bone marrow 
granulocytopenia was not complete but became functionally limiting during bacterial 
super-infection, where large numbers of bone marrow-derived granulocytes are 
required to control bacterial lesions. During these experiments, granulocyte numbers 
were also monitored in blood. While naïve mice and LCMV pre-infected IFNAR-/- 
animals increased granulocytes in blood during L.m. infection, LCMV-infected 
wildtype animals were unable to mount reactive granulocytosis upon super-infection 
(Fig. 4b). Recent reports have implicated a detrimental effect of IFN I during L.m. 
infection partly by acting on T cells (Auerbuch, Brockstedt et al. 2004; Carrero, 
Calderon et al. 2004; O'Connell, Saha et al. 2004; Carrero, Calderon et al. 2006). 
Although at the dose of L.m. and in the 129/SvEv background we were using, these 
L.m. titer differences were marginal, our findings pointed in the same direction as the 
results of these recent studies. The toll-like receptor 3 ligand Poly(I:C) has been 
described to increase susceptibility to L.m. infection (O'Connell, Saha et al. 2004). 
We therefore analysed whether Poly(I:C) affects the granulocyte compartment similar 
to a LCMV pre-infection. IFNAR-competent and -deficient mice were infected with 
5x103 cfu L.m. and treated with 200μg Poly(I:C) at the day of infection. As described, 
this treatment resulted in increased L.m. titers only in IFNAR-expressing animals at 
day 3 of the L.m. infection (Supplementary Fig. 4a). When bone marrow granulocytes 
were analysed, Poly(I:C) treated wild-type animals showed increased activation  
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(Supplementary Fig. 4b) and apoptosis (Supplementary Fig. 4c) within the 
granulocyte compartment that was reduced in numbers (Supplementary Fig. 4d,e,f). 
Poly(I:C) treatment alone also resulted in IFNAR-dependent reduction of granulocyte 
numbers and increased apoptosis in the bone marrow (Supplementary Fig. 4g,h). 
To determine whether susceptibility to super-infection extended to other bacteria, the 
mostly extracellular bacterium S. aureus was analysed. IFNAR-/- mice were pre-
infected with LCMV and challenged two days later with S. aureus. After 24 hours, 
LCMV-infected wildtype mice demonstrated drastic clinical disease as well as 100-
fold higher bacterial titers in lung and kidney when compared to IFNAR-/- mice (Fig. 
4e). When LCMV-infected C57BL/6 mice were tested to exclude mouse-strain 
dependence of the observation, also 100-fold increased bacterial organ titers were 
measured in LCMV pre-infected animals compared to control mice (not shown). To 
determine whether virus-induced granulocytopenia would also heighten susceptibility 
to a gram-negative super-infection, we tested Salmonella typhimurium (S. typhim.) in 
C57BL/6 mice (Conlan 1997). At day 2 of LCMV infection, 1.2*104 cfu S. typhim. 
were given intravenously. Bacterial titers were elevated at day 3 in spleen and liver in 
LCMV pre-infected compared to unpretreated mice (Fig. 4f). 
To test whether bacterial super-infection at the onset of bone marrow granulocyte 
recovery after LCMV infection would be cleared normally, we infected C57BL/6 mice 
with 5000 L.m. at day 5 after LCMV. Interestingly, and perhaps, as might be 
expected at this later timepoint, mice cleared these infections better than controls 
(Supp. Fig. 1). 
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6.5 Discussion 
The virus-induced suppression of anti-bacterial immunity is characterized by type I 
interferon production followed by apoptosis of bone marrow granulocytes, which in 
turn causes impaired granulocyte emigration to sites of bacterial infection. This 
granulocytopenia is not complete but became functionally limiting during super-
infection, where large numbers of bone marrow-derived granulocytes were rapidly 
required to control L.m., S. aureus or S. typhimurium. Since LCMV is not cytopathic 
in its physiological murine host, direct cell destruction by replicating virus is not 
necessary for enhancement of bacterial super-infection.  
In addition to systemic effects, local virus-induced alterations including enzymatic 
uncovering of bacterial binding sites on host cells (McCullers and Bartmess 2003), 
lysis of epithelial cells by cytopathic viruses (Black 2003), that may break 
antibacterial barriers (Bakaletz 1995), and enhanced bacterial binding to virus-
encoded receptors that are expressed on infected host cells (Okamoto, Kawabata et 
al. 2003) may additionally facilitate bacterial super-infection. Interferon-induced 
granulocyte apoptosis could also explain often observed sepsis following burn 
injuries or ischemic stroke (Davenport, Dennis et al. 1996; Hotchkiss, Coopersmith et 
al. 2005; Sharma, Harish et al. 2006). From the virus’ point of view, the induction of 
innate antiviral IFN I, by depleting granulocytes, may also diminish later adaptive 
immune responses (Slifka, Homann et al. 2003; Hahm, Trifilo et al. 2005; 
Molesworth-Kenyon, Oakes et al. 2005) and may thus favour virus persistence. 
Neutropenia is a regular symptom of virus infections such as EBV (Hammond, Harlan 
et al. 1979) and HIV (Colson, Foucault et al. 2005). Interferon type I as a therapeutic 
agent has also been shown to induce granulocytopenia (Urbaniak, Halliday et al. 
1978; Gutterman, Fine et al. 1982), and Hepatitis C and B patients receiving 
therapeutic type I IFN have been shown to have an increased risk for bacterial super-
infections when rendered neutropenic by the treatment (Hoofnagle and di Bisceglie 
1997; Puoti, Babudieri et al. 2004).  
Taken together, our findings suggest that virus-induced granulocytopenia may 
critically contribute to bacterial super-infections. Efforts to block this effect, possibly 
with preventive G-CSF application or perhaps even cautious anti-IFN I treatments 
during the acute phase of the virus infection could ameliorate the outcome of the 
described clinical constellation. 
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6.7 Figure legends: 
Fig. 1: Increased susceptibility to bacterial infection early during LCMV-induced 
bone marrow granulocytopenia 
(A) Experimental protocol. (B) Bacterial titers in spleen and liver at day 3 of 
infection. C57BL/6 mice were infected with 2x106 pfu LCMV-WE i.v. 48 hours 
before infection with 5x103 cfu (1/5 LD50) Listeria monocytogenes (L.m.) i.v. For 
comparison, 120μg of granulocyte-depleting antibody anti-GR1 NimpR14 was 
given i.v. at day 1 after L.m. infection in an additional group of mice (mean +/- 
SEM of 4-6 animals per group, one of three experiments). (C) C57BL/6 mice were 
infected with LCMV at day -2, and infected with 1x103 (1/10 LD50) or 5x103 (1/2 
LD50) cfu L.m. at day 0. Survival was monitored twice daily (n=9-10 per group). 
(D) Bone marrow granulocytes (GRC, Ly6G+CD11b+) cell numbers measured by 
FACS at day 5 after LCMV and day 3 after L.m. super-infection (n=4-6 animals 
per group, one of three experiments). (E) Bone marrow GRC (black) of C57BL/6 
mice after infection with 2x106 pfu LCMV-WE i.v., percentage of Annexin V+ of 
GRC (red) (mean +/- SEM, n=3-4 per group, one of two experiments with similar 
results). G-CSF concentration in serum (blue) (mean +/- SEM,  n=3-4 per group). 
 
Fig. 2: Activation-associated cell death of bone marrow GRC during LCMV 
infection leads to impaired granulocytic infiltration 
(A) Upregulation of CD11b surface expression on bone marrow GRC during 
LCMV infection (n=3-4 animals per timepoint, mean fluorescence intensity +/- 
SEM). (B) Phagocytosis of CFSE-labelled L.m. in vitro by BM GRC (MOI 20:1) at 
day 2 after LCMV infection after 1 hour of co-incubation. Mean fluorescence 
intensity of 7-AAD-neg. GRC (one of two experiments with similar results). (C) 
NADPH Oxidase activity in 7-AAD-neg. BM GRC as measured by DHR123 
fluorescence (534nm) in vitro upon co-incubation with L.m. for 1 hour at day 2 
after LCMV infection (one of three experiments with similar results). (D) 
Percentage of dead (7-AAD+) bone marrow GRC from LCMV pre-infected 
C57BL/6 mice or control mice after incubation with or without L.m. in vitro for 1 
hour. (one of two experiments with similar results). (E) Numbers of hepatic and 
splenic GRC 4 hours after L.m. challenge (107 cfu i.v.) in C57BL/6 mice at day 3 
after 2x106 pfu LCMV infection (one of two experiments with similar results). (F) 
Numbers of peritoneal GRC 4 hours after administration of 1ml thioglycolate i.p. in 
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C57BL/6 mice at day 3 after LCMV infection (one of two experiments with similar 
results).  
 
Fig. 3: Type I interferon dependent bone marrow GRC apoptosis  
(A) Serum interferon type I in LCMV infected C57BL/6 mice (n=3-4, mean +/- 
SEM). (B) Numbers of bone marrow GRC of IFNAR-/- and control mice at day 3 
after LCMV infection or without virus infection (one of two experiments with similar 
results). (C) Percentages of apoptotic (Annexin V+) bone marrow GRC of IFNAR-/- 
and control mice at day 3 after LCMV infection or without virus infection (n=3 
animals per group, mean +/- SEM, one of two experiments with similar results). 
(D) Apoptotic GRC (Ly6G+) after 72 hours in vitro bone marrow culture of wildtype 
and IFNAR-/- mice with increasing amounts of recombinant interferon α or β (one 
of two similar experiments).  
 
Fig. 4: Interferon type I dependent granulocytopenia and absence of granulocyte 
infiltrates at the site of bacterial infection 
(A) IFNAR-/- mice and wild-type mice were infected with LCMV 48 hours before 
super-infection with 5x103 L.m. Two days later, L.m. titers were determined (n=3-
4 per group, one of three comparable experiments is shown, mean +/- SEM). (B) 
Numbers of peripheral blood GRC (n=3-4 per group, one of two experiments, 
mean +/- SEM). (C) Immunohistochemistry of GRC (GR-1) in liver and (D) spleen 
and of L.m. (rabbit anti-L.m.) in sequential sections at day 2 after super-infection 
with L.m. in LCMV infected IFNAR-/- or control wildtype mice (two experiments 
with similar results). (E) IFNAR-/- mice and control mice were infected with LCMV 
at day -2 and super-infected at day 0 with 2x107 cfu S. aureus. 24 hours later, S. 
aureus titers were determined (n=3-4 per group, mean +/- SEM). (F) C57BL/6 
mice infected with LCMV at day -2 were super-infected with 1.2*104 S. 
typhimurium i.v. and bacterial titers determined at day 3. 
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Supplementary Fig. 1: When super-infection occurs at the onset of bone marrow 
granulocyte recovery, L.m. clearance is enhanced  
(A) Experimental protocol (B) C57BL/6 mice were infected with LCMV at day -5, 
and infected with 5x103 cfu L.m. at day 0. At day 3, bacterial titers were 
determined in spleen and liver (n= 3-4 per group, one experiment). 
 
Supplementary Fig. 2: LCMV-induced apoptosis is specific for bone marrow GRC  
(A) Time-course of splenic and hepatic macrophages stained with F4/80 after 
infection of C57BL/6 mice with 2x106 pfu LCMV WE (representative examples, 
one experiment, n=3). (B) Numbers of bone marrow T (CD3e+), B (B220+) and NK 
cells (NK1.1+) after infection with 2x106 pfu LCMV WE (one experiment, mean +/- 
SEM). (C) Percentage of apoptotic (Annexin V+) bone marrow GRC and non-GRC 
at day 3 of LCMV infection or in naïve mice (one of three experiments with similar 
results, mean +/- SEM). (D) Blood GRC numbers during 2x106 pfu LCMV WE 
infection of C57BL/6 mice. (one of two experiments with similar results, mean +/- 
SEM) (E) Immunohistochemistry of GRC (GR-1) during LCMV infection of 
C57BL/6 mice (representative examples, one experiment, n=3).  
 
Supplementary Fig. 3: Interferon type I dependent granulocytopenia during LCMV 
infection leads to absence of granulocytes, but not macrophages, at the site of 
infection 
At day 2 after L.m. super-infection of LCMV-WE pre-infected mice, livers of 
wildtype and IFNAR-/- mice were stained for the presence of granulocytes (GR-1), 
tissue macrophages (F4/80) and L.m. antigen (representative examples, n=3-4, 
two experiments with similar results). 
 
Supplementary Fig. 4: Poly(I:C) treatment upon L.m. infection leads to type I IFN 
dependent heightened BM GRC activation, apoptosis, decreased BM GRC 
numbers and elevated L.m. organ titers. Poly(I:C) treatment in naïve mice 
reduces granulocyte numbers in bone marrow and induces apoptosis.  
(A) L.m. liver titers at day 3 after infection of IFNAR-/- or wild type mice with 5x103 
L.m. with or without concomitant administration of 200μg Poly(I:C) i.v. at the day 
of infection (n=3 mice per group, mean +/- SEM, one of two experiments with 
similar results). (B) CD11b surface expression on bone marrow GRC  
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(Ly6G+CD11b+) (n=3 per group, mean +/- SEM, one of two experiments with 
similar results). (C) Percentage of apoptotic (Annexin V+) bone marrow GRC and 
(D) percent and (E) numbers of bone marrow GRC at day 3 after L.m. infection 
(n=3 per group, mean +/- SEM, one of two experiments with similar results). (F) 
Representative FACS plots of (D). (G) Numbers of bone marrow GRC and (H) 
percentage of apoptotic GRC are shown 48 hours after administration of 200 μg 
Poly(I:C) i.v. (n=3 per group, one experiment). 
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7. Disruption of the bone marrow granulocyte supply and 
uncontrolled bacterial proliferation by TLR2 activation 
 
7.1 Abstract 
Bacterial infections are normally quickly controlled by granulocytes. After 
phagocytosis and exertion of their antibacterial function, granulocytes undergo cell 
death, forming pus. Therefore, rapid and constant supply from the bone marrow is 
needed to control bacterial abscesses. Here we show that when TLR2/6 ligands 
reach the circulation and spread systemically during an innocuous bacterial infection, 
the essential granulocyte supply in the bone marrow can be activated and destroyed, 
resulting in unchecked bacterial proliferation, sepsis and death. This mechanism 
could be relevant in the pathophysiology of sepsis. 
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7.2 Introduction 
The first infiltrating cells to counter a bacterial infection are the granulocytes. They 
emigrate from the bone marrow to the blood stream and enter target tissues. In 
circulation, granulocytes have a short half-life of about 8 hours. The bone marrow 
contains a great number of functional granulocytes (Boxio, Bossenmeyer-Pourie et 
al. 2004) and the marrow reserve can be mobilised in emergency response to 
bacterial infections. Numbers of granulocytes reflect bacteremia and sepsis. The high 
mortality of sepsis has been attributed to an immune overactivation which is linked to 
a failure of bacterial clearance. The biological mechanisms causing fatal sepsis 
remain equivocal. Here we analyzed a low-dose infection with Listeria 
monocytogenes in mice. To mimick immune overactivation, we administered the 
TLR2/6 ligand Pam2Cys, a Mycoplasma fermentans-derived lipopeptide consisting of 
palmitoyl side chains acid and a cysteine (Jackson, Lau et al. 2004) or FSL-1, a 
ligand based on the Mycoplasma salivarium lipoprotein (Shibata, Hasebe et al. 
2000). We found that systemic activation of TLR2 by Pam2Cys or FSL-1 resulted in 
suppression of the bone marrow granulocyte reserve and in uncontrolled bacterial 
proliferation. 
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7.3 Material and Methods: 
Mice 
Specific pathogen free (SPF) laboratory mice were from the institute of 
Labortierkunde of the veterinary facility of the University of Zurich. Experiments were 
performed according to Swiss veterinary law and institutional guidelines. C57BL/6 or 
TLR2-/- mice between 6-10 weeks old were used. 
Infections 
Listeria monocytogenes (L.m.) strain 10403S grown overnight in Brain Heart infusion 
broth, washed two times in PBS and frozen at -80°C. Inocula were prepared from 
thawed aliquots and injected i.v. in 200 μl. Administered lipopeptides were Pam2Cys, 
a Mycoplasma fermentans-derived lipopeptide consisting of palmitoyl side chains 
acid and a cysteine, S-(2,3-bis(palmitoyloxy)propyl) cysteine) (Jackson, Lau et al. 
2004) and FSL-1, a ligand based on the Mycoplasma salivarium lipoprotein with the 
formula S-(2,3-bispalmitoyloxypropyl)-Cys-Gly-Asp-Pro-Lys-His-Pro-Lys-Ser-Phe 
(Shibata, Hasebe et al. 2000). 
Bacterial titer  
Bacterial titers were determined in homogenized halfs of spleen, the left lobe of the 
liver, in PBS with serial dilutions plated on brain heart infusion or blood agar plates.  
Bone marrow aspirates and culture  
Bone marrow cells were flushed with PBS from the femur and were stained for FACS 
analysis or cultured in RPMI with 10% FCS.  
FACS and antibodies 
Anti-Ly6G, GR1, CD11b, Annexin V and 7-Amino-Actinomycin-D (7-AAD) were 
obtained from BD, Basel. Cells expressing Ly6G / GR1 and CD11b are termed 
“GRC”. FSC/SSC gates were used to exclude debris in organ homogenates and 
peritoneal washings. Dihydrorhodamine 123 (DHR, Sigma) was used for measuring 
NADPH oxidase activity by measuring cellular fluorescence in FL1 channel (emission 
534nm). A fixed number of fluroescent APC beads were used to quantify cell number 
per sample volume as has been described before. Anti-GR1 (NimpR14) hybridoma 
was a generous gift from Dr Tacchini-Cottier, WHO, Geneva. 
 71
Histology 
Histological samples were snap-frozen in Hanks medium and stained with an anti-
L.m. rabbit serum (a gift from Prof J. Bille, Lausanne), Gr-1 (Pharmingen) antibodies. 
Staining was developed using a goat anti-rat antibody (Caltag Laboratories) or goat 
anti-rabbit (Jackson Immuno Research) and an alkaline phosphatase-coupled 
donkey anti-goat antibody (Jackson Immuno Research) with naphthol AS-BI (6-
bromo-2-hydroxy-3-naphtholic acid 2-methoxy anilide) phosphate and new fuchsin as 
a substrate. The presence of alkaline phosphatase activity yielded a red reaction 
product. The sections were counterstained with hemalum. 
Statistical analysis 
In all figures, unpaired two-sided t test or one-way analysis of variance (ANOVA) was 
used. P values above 0.05 were not considered significant. * for p<0.05, ** for 
p<0.01, *** for p<0.001. 
End notes:  
A.A. Navarini and K. Lang have contributed equally to this work. 
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7.4 Results 
To evaluate bone marrow granulocytes during TLR2/6 stimulation, we administered 
100 μg of the lipopeptide Pam2Cys intravenously in C57BL/6 mice. After 24 hours, 
we investigated the number of granulocytes within the bone marrow (Fig. 1a). 
Surprisingly, granulocytes (Ly6G+CD11b+) were reduced by 90-95% numerically and 
by percentage (Fig. 1b). This reduction could have resulted from two effects – on one 
hand, granulocytes leaving the bone marrow, on the other hand, granulocyte death 
within the bone marrow. When the percentage of granulocytes that had entered 
apoptosis after Pam2Cys treatment was measured, up to 30% of granulocytes were 
apoptotic compared to 10% in controls (Fig. 1c). TLR2-/- granulocytes instead were 
almost completely resistant to this stimulus, proving that TLR2 engagement was 
required for the observed granulocyte loss. The strong reduction and apoptosis was 
specific for granulocytes as monocytic precursors that were CD11b+ and M-
CSF(CD115)+ were not reduced by TLR2/6 ligation (Supp. Fig. 1a). To determine 
whether Pam2Cys also provoked granulocyte emigration from the bone marrow, the 
number of granulocytes in the spleen (Fig. 1d) and liver (Supp. Fig 1b) was 
measured. We found that Pam2Cys treatment resulted in great accumulation of 
apoptotic, but not viable granulocytes in the spleen (Suratt, Young et al. 2001). In the 
liver, no increase of granulocytes could be demonstrated. Therefore, Pam2Cys 
induced bone marrow apoptosis and emigration of pre- and fully apoptotic 
granulocytes. In the blood, no significant increase of granulocytes could be measured 
(Supp. Fig. 1c).  
We wondered whether the observed granulocyte death was associated with 
activation. When an early activation marker, the  β2-integrin CD11b (Witthaut, 
Farhood et al. 1994) was tested, a clear difference between Pam2Cys treated and 
control granulocytes was observed (Fig. 1e). TLR2-/- bone marrow granulocytes 
showed elevated CD11b expression compared to controls in the naïve state, 
however this was not further increased by Pam2Cys treatment. When granulocytes 
are fully activated, they activate the destructive respiratory burst machinery that 
eventually results in their own cell death (Watson, Redmond et al. 1996; Engelich, 
White et al. 2002). To analyze granulocyte oxidative burst, the mean fluorescence of 
granulocytes after incubation with Dihydrorhodamine 123 was measured. TLR2 
ligation by Pam2Cys resulted in specific activation of the respiratory burst (Fig. 1f).  
To determine whether these effects could be re-produced by direct incubation of  
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bone marrow with TLR2/6 ligands, Pam2Cys (or FSL-1, not shown but similar 
results) were added in increasing amounts to C57BL/6 bone marrow eluates. 24 
hours later, activation and apoptosis was measured. Both reagents induced 
activation starting from 1ng/ml (Fig. 2a,b,c), with full- blown activation at 10 and 100 
μg/ml. Reaction to Pam2Cys in vitro was mainly TLR2-dependent, however, with the 
highest dose, also some reaction by TLR2-/- bone marrow was detected, which might 
be possibly mediated by TLR6 known to also interact with lipopeptides (Takeuchi, 
Sato et al. 2002). Therefore, systemic circulation of soluble TLR2 ligands resulted in 
activation and depletion of the bone marrow granulocyte reserve. As during bacterial 
infections such as listeriosis, contact of bacterial products can occur with the blood 
stream, we wondered whether a bout of circulating bacterial products could therefore 
significantly influence the prognosis of a low-level infection.  
Therefore, C57BL/6 mice or TLR2-/- controls were infected with 1000 cfu L.m. 
intravenously (Fig. 3a). This dose is sublethal in C57BL/6 mice, 1/10 LD50. At day 1 
of infection, the TLR2/6 ligand Pam2Cys was administered in a dose of 100 μg. 2 
days later, at day 3 of the bacterial infection, the bacterial titers were measured (Fig. 
3b). The Pam2Cys treated animals’ organs showed 10 to 100 fold higher bacterial 
titers than controls. TLR2-/- animals were resistant to the effects of Pam2Cys. As 
comparison for complete absence of granulocytic activity, a granulocyte depleting 
antibody (NimpR14, anti-GR1) was used. 100 μg anti-GR1 were given on day 1 of 
the L.m. infection, which similarly lead to increased bacterial titers. To determine 
whether this was associated with decreased supply of granulocytes, we measured 
numbers of Ly6G+CD11b+ cells in the blood (not shown) and bone marrow (Fig. 3c). 
Both in blood and in bone marrow, granulocytes were strongly depleted in the 
Pam2Cys treated animals. TLR2-/- mice treated with Pam2Cys or PBS at day 1 of 
the infection survived the infection, as did PBS-treated wildtype mice. Pam2Cys-
treated wildtype mice however developed clinical disease at day 4-5. 
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By immunohistochemistry, granulocyte-dependent containment of L.m. was 
investigated in the liver (Fig. 3e). Untreated animals harboured few bacteria, which 
were densely packed with infiltrating granulocytes at day 3 of the infection. The 
Pam2Cys treated animals showed multiple liver foci consisting of bacterial lesions, 
whereas infiltrating granulocytes were almost completely lacking. Taken together, 
Pam2Cys treated animals were highly susceptible to Listeria which correlated with  
granulocytopenia in bone marrow and target organs. 
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7.5 Discussion 
Here we report that TLR2/6 ligands reaching the systemic circulation activated and 
destroyed the bone marrow granulocyte supply. When this occurred during a non-
lethal bacterial infection, decreased containment of bacteria was found, leading to 
lowered survival.  
In clinical medicine, it is well known that granulocytes are essential for overcoming 
bacterial infections (Watts 1999). One of the important predictors of susceptibility to 
bacterial infection is neutropenia and agranulocytosis (Finberg and Talcott 1999). 
Neutropenia is for example observed in cancer therapy, as part of haematologic 
diseases. Importantly, administration of type I interferon is a known cause for 
neutropenia in humans and in mice, underlining that innate immune activation may 
be detrimental for granulocytes (Navarini, Recher et al. 2006). Since 30 years, many 
studies with granulocyte transfusions have been attempted to achieve protection 
during bacterial infections in neutropenic patients (Graw, Herzig et al. 1972; Herzig, 
Herzig et al. 1977; Stanworth, Massey et al. 2005), however with conflicting results. 
Possibly, the transfused peripheral blood granulocytes had too short a half-life. 
Today, with advanced cell culture techniques, it might be possible to transfuse earlier 
maturation states of granulopoiesis that might form a better reservoir. In our hands 
we have observed that transfused bone marrow granulocytes homed efficiently to the 
bone marrow, but only when no bacterial infection was already active in the recipient 
(manuscript in preparation). Nevertheless, the amplification of granulopoesis by 
administration of GM-CSF is already commonly used to shorten the duration of 
neutropenia following cancer treatment. 
Sepsis means a bacterial infection combined with a systemic inflammatory reaction 
syndrome (SIRS) (Muckart and Bhagwanjee 1997). It is defined by presence of 
>12000 or <4000 leukocytes per μl blood (which are mainly granulocytes in humans), 
and reactions of the heart (tachycardia), lungs (hypoxaemia) and the brain (fever or 
hypothermia). Sepsis has a high mortality. Since high cytokine concentrations are 
linked to a poor outcome (Osuchowski, Welch et al. 2006), it is generally believed 
that lethal sepsis is linked to immune overactivation. However, immunmodulating 
therapies such as anti TNF antibodies (Abraham, Wunderink et al. 1995) alone have 
failed so far. Our results might implicate that immune overactivation during sepsis 
might reduce the available granulocyte pool in the bone marrow and thereby reduce 
the antibacterial immune response. 
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At the dosages used, Pam2Cys did not induce a shock-like syndrome when 
administered to mice – on the contrary, mice remained completely symptom-free. 
Interestingly, similar dosages are used regularly for priming of T cells (Zhang, 
Issagholian et al. 2005).  
What other stimuli can lead to the observed effects on granulocytes? In this study, 
we tested only TLR2 ligands. However, to our opinion it is likely that also during 
gram-negative infection, stimulatory molecules such as LPS act on the bone marrow 
as resistance-lowering agents. Interestingly, after activation by Pam2Cys and during 
sepsis, macrophage numbers are not suppressed (Supp Fig. 1b) and (Ellaban, 
Bolgos et al. 2004). As during sepsis, TNF-α has been implicated to result in 
immunosuppression, we have tested TNF receptor 1 -/- mice, which showed similar 
bone marrow granulocyte suppression as wildtype mice (not shown). As we had 
identified a proapoptotic effect on bone marrow granulocytes by IFN I (chapter 6), we 
treated also IFNAR-/- as well as IFNG-/- mice with Pam2Cys, which however 
resulted in similar bone marrow granulocyte apoptosis as wildtype controls (not 
shown).  
Taken together, our results demonstrate that during an innocuous bacterial infection, 
an additional rather weak (non-toxic) immunstimulation via TLR engagement may 
have fatal consequences. Our results show that immune overactivation may be 
linked with granulocyte apoptosis within the bone marrow and may help to explain 
sepsis. 
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7.7 Figure legends: 
Fig. 1: Decreased granulocyte numbers in bone marrow, enhanced activation-
associated apoptosis and sequestration of apoptotic granulocytes in the spleen 
after Pam2Cys administration. 
 
(A) Bone marrow granulocytes (GRC, Ly6G+CD11b+) cell numbers or (B) 
percentages measured by FACS 24 hours after administration of 100 μg 
Pam2Cys i.v. (Mean +/- SEM, n=3-5 animals per group, one of two experiments 
with similar outcome). (C) Percentage of apoptotic (AnnexinV+7AAD+) GRC in 
bone marrow 24 hours after 100 μg Pam2Cys i.v. (Mean +/- SEM, n=3-5 animals 
per group, one of two experiments with similar outcome). (D) Number of 
granulocytes in spleens 24 hours after administration of 100 μg Pam2Cys, black 
bars show non-apoptotic (7AAD-AnnexinV-) granulocytes, red bars show 
AnnexinV+7AAD+/- GRC (Mean +/- SEM, n=3-5 animals per group, one of two 
experiments with similar outcome). (E) Mean fluorescence intensity of CD11b 
surface staining on bone marrow GRC 24 hours after administration of 100 μg 
Pam2Cys i.v. (Mean +/- SEM, n=3-5 animals per group, one of two experiments 
with similar outcome). (F) Mean fluorescence intensity of DHR123 staining in 
bone marrow GRC 24 hours after administration of 100 μg Pam2Cys i.v. (Mean 
+/- SEM, n=3-5 animals per group, one of two experiments with similar outcome). 
 
Fig. 2: Pam2Cys treatment of bone marrow in vitro results in dose-dependent 
activation and cell death 
 
(A) Mean fluorescence intensity of DHR123 staining in bone marrow granulocytes 
incubated for 24 hours with different amounts of Pam2Cys (Mean +/- SEM, n=4, 
one experiment) (B) Mean fluorescence intensity of CD11b staining on bone 
marrow granulocytes incubated for 24 hours with different amounts of Pam2Cys 
(Mean +/- SEM, n=4, one experiment). (C) Percentage of dead (7AAD+) bone 
marrow granulocytes after 24 hours of incubation with different amounts of 
Pam2Cys (Mean +/- SEM, n=4, one experiment).  
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Fig. 3: Systemic TLR2 ligation during non-lethal bacterial infection leads to 
absence of abscess-associated granulocytes and uncontrolled bacterial 
propagation  
 
(A) Experimental protocol (B) Survival curve of TLR2-/- or wildtype mice treated 
with 100μg Pam2Cys or PBS at day 1 of infection with 1000 cfu Listeria 
monocytogenes (n=5-11 per group). (C) Bacterial organ titers at day 3 of infection 
with 1000 cfu Listeria monocytogenes with or without administration of 100 μg 
Pam2Cys 24 hours after infection. Green bars show C57BL/6 controls that had 
received 100 μg anti-GR1 antibody at 24 hours after infection. (Mean +/- SEM, 
n=3, one of two experiments with similar outcome). (D) Bone marrow 
granulocytes at day 3 of the listerial infection. (Mean +/- SEM, n=3, one of two 
experiments with similar outcome). (E) Immunohistochemistry of livers at day 3 of 
listerial infection stained for GR1 (GRC)  or anti-L.m. serum. Injection of PBS at 
day 1 shown on the left, administration of 100 μg Pam2Cys at day 1 to the right. 
 
Supplementary Figure 1:  
 
(A) Pam2Cys administration does not suppress bone marrow monocytes: 
Numbers of M-CSF-R+(CD115+)CD11b+ cells in bone marrow 24 hours after 
administration of 100 μg Pam2Cys i.v. 
 
(B) Granulocyte sequestration does not take place in the liver:  
Number of granulocytes in livers 24 hours after administration of 100 μg 
Pam2Cys, black bars show non-apoptotic (7AAD-AnnexinV-) granulocytes, red 
bars show AnnexinV+7AAD+/- GRC (Mean +/- SEM, n=3 animals per group, one 
experiment). 
 
(C) Blood granulocytes are not significantly suppressed after administration of 
Pam2Cys: Numbers of granulocytes in blood 24 hours after administration of 100 
μg Pam2Cys i.v. 
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8. TLR4 ligation results in prolonged innate resistance to bacterial 
challenge 
 
8.1 Abstract 
Antigen-specific immunity greatly increases survival of reinfections. Here we 
evaluated how administration of lipopolysaccharide as an antigen-unrelated stimulus 
resulted in increased resistance to the grampositive bacterium Listeria 
monocytogenes. Prolonged "innate immunity" was short lived, unspecific and mainly 
resulted from induction of granulocyte numbers in the bone marrow. Short term, 
unspecific innate resistance effects by past events may have great significance in 
host survival, particularly when living in pathogen-rich environments.  
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8.2 Introduction 
An organism challenged with a sublethal infection usually develops strong adaptive 
immunity against the pathogen, and therefore can specifically react against a second 
challenge. This often results in heightened chances of survival of a second infection. 
Maintenance of sufficiently high neutralizing antibody titers correlates with protection 
against acute cytopathic infections.  Maternal antibodies are transmitted to offspring 
and play an important role in early survival (Zinkernagel 2001). Because adaptive 
immune responses are antigen-specific, the first encounter of a new infection induces 
a primary adaptive response that takes several days to develop.  
Thus, the subject may at first be initially unprotected by adaptive memory. In addition 
to adaptive immunity, innate resistance mechanisms, particularly by granulocytes 
and macrophages, play an important role in resistance to infections (Janeway and 
Medzhitov 2002). To date, it is unclear whether past activation of the innate immune 
system can produce lasting effects and for how long, whether this can contribute to 
resistance against pathogens, and which cells mediate such effects. Several studies 
have reported unspecific increased resistance against pathogens after prior 
stimulation by activating agents that cannot be readily explained by adaptive memory 
(Medina, Vas et al. 1975; Uchiya and Sugihara 1989). Instead, the concept of 
induced unspecific activation was used to explain resistance against many 
pathogens after an experimentally defined single  stimulation. This resistance was 
described as lasting from 24 hours (Noursadeghi, Bickerstaff et al. 2002) up to 60 
days (Baughn and Bonventre 1975; Medina, Vas et al. 1975). While adaptive 
immunity is often protective for months to years, the wide spectrum of innate 
resistance renders understanding of memory-like aspects of innate immunity 
potentially interesting.  
Here we evaluated whether hosts that recently had encountered an innate activating 
stimulus would fare better against a new pathogen and if so, for how long this could 
such preparedness could last.  
These questions were evaluated by stimulation of the innate immune system with the 
TLR4 ligand lipopolysaccharide. Changes in the respective innate cell types were 
investigated by histology and FACS. Protection against a challenge infection was 
assessed with Listeria monocytogenes (L.m.) infection. This gram-positive, 
lipopolysaccharide-negative bacterium initially targets liver and spleen and replicates 
intra- and extracellularly. The host response has two phases, first mediated 
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predominantly by granulocytes, the later phase initiated by day 3 is mediated by 
CD8+ and CD4+ T lymphocyte-induced macrophage activation.   
We show that an innate activation state can be measured by elevation of granulocyte 
numbers in bone marrow and CD11b upregulation. Our experiments here show that 
TLR4 ligand administration caused granulocyte accumulation and activation, that 
correlated with increased survival.  
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8.3 Material and Methods: 
 
Mice 
Specific pathogen free (SPF) C57BL/6 mice (6-10 weeks old) were from the institute 
of Labortierkunde, University of Zurich. Experiments were performed according to 
Swiss ethical protection laws and institutional guidelines.  
Infections 
Listeria monocytogenes (L.m.) strain 10403S were grown overnight in Brain Heart 
infusion broth, washed two times in PBS and frozen at -80°C. Inocula were prepared 
from thawed aliquots and injected i.v. in 200 μl.  
Bacterial titer  
Bacterial titers were determined in homogenized ½ spleen and of the left lobe of the 
liver. Serial dilutions in PBS were plated on brain heart infusion plates.  
Bone marrow aspirates and culture  
Bone marrow cells were flushed with PBS from the femur and were stained for FACS 
analysis or cultured in RPMI with 10% FCS.  
FACS and antibodies 
Anti-Ly6G, GR1, CD11b, Annexin V and 7-Amino-Actinomycin-D (7-AAD) were 
obtained from BD, Basel. Cells expressing Ly6G / GR1 and CD11b are termed 
“GRC”. FSC/SSC gates were used to exclude debris in organ homogenates. A fixed 
number of fluorescent APC beads were used to quantify cell number per sample 
volume as has been described before (REF). Anti-GR1 (NimpR14) hybridoma was a 
generous gift from Dr. Tacchini-Cottier, WHO, Geneva. 
Statistical analysis 
In all figures, unpaired two-sided t test or one-way analysis of variance (ANOVA) was 
used. P values above 0.05 were not considered significant. * for p<0.05, ** for 
p<0.01, *** for p<0.001. 
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8.4 Results 
C57BL/6 mice were treated with 300μg LPS i.v. and analysed during 14 days. To 
assess changes in the innate immune system, phagocyte numbers were measured 
as follows. Granulocyte numbers in bone marrow eluates were measured by FACS 
for Ly6G+CD11b+ cell count at different timepoints after i.v. administration of 300μg 
LPS. At 24 hours, a drastic reduction of granulocyte numbers was found in the bone 
marrow. However, granulocyte numbers had recovered by day 5, leading to an 
increase of up to 200% of the original numbers by day 7 and 9, thereafter they 
decreased during the following 5 days (Fig. 1a). At day 7 and 9, the remaining (Ly6G-
negative CD11b-negative) bone marrow cells were reduced in number (Fig. 1a). 
When blood granulocytes were investigated, we found that numbers were within 
normal ranges at 24 hours. By day 7 they had increased corresponding to the 
reserve in the bone marrow. Monocytes also arise from the bone marrow. 
Measurement of the monocytes by defined by Ly6C+CD11b+Ly6G- staining in bone 
marrow eluates at the different timepoints after LPS administration revealed no 
drastic variation in numbers (Fig. 1a).  
In addition to monocytes and granulocytes, fixed macrophages are the remaining 
important phagocytic compartment that contributes to antibacterial defense. To 
determine whether their activation status after LPS treatment, their activity was 
assessed by the activation markers CD80, CD86 and MHC II (I-Ab) in the spleen and 
liver (Fig. 1b). Surprisingly, all three markers showed a trend to downregulation at 
day 7 after LPS treatment. Immunohistochemistry showed that tissue macrophages 
were present during the whole period until day 14 (not shown). 
Taken together, LPS treatment influenced predominantly granulocyte numbers in the 
bone marrow. This treatment also altered their bactericidal activity, assessed with the 
model infection of mice with Listeria monocytogenes. These gram-positive bacteria 
target the liver and spleen and replicate intra- and extracellularly. The host response 
has two phases, the first being mediated predominantly by granulocytes, the later 
phase initiated by day 4 is mediated by CD8+ and CD4+ T lymphocyte-induced 
macrophage activation.  
C57BL/6 mice were treated with 300μg LPS, and infected with 10’000 cfu L.m. 7 
days later (Fig. 1c). At day 3 of the infection, bacterial titers were determined in the 
spleen and liver (Fig. 1d). Both organs of LPS-pretreated animals had 5-20 fold lower 
bacterial colonies than PBS-pretreated controls. When in addition on day 1 of the 
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bacterial infection, 100 μg of the granulocyte-depleting antibody anti-GR1 was 
administrated, the titer difference was abrogated, indicating that presence and 
efficiency of granulocytes correlated with the LPS-induced antibacterial resistance. 
LPS-pretreated mice survived better than PBS-treated controls after L.m. infection 
with 3-5 LD50 (Fig. 1e). LPS- or PBS-pretreated C57BL/6 mice were given 3x104 cfu 
or 5x104 cfu L.m. at day 7 and monitored for signs of disease. Control mice all 
succumbed at day 3-4 to the infection, while LPS-pretreated animals showed 75% 
survival to 3x104 cfu and 25% to 5x104 cfu L.m. Taken together, our results 
demonstrated increased anti-bacterial resistance induced by administration of 
lipopolysaccharide. This resistance correlated with bone marrow granulocytosis and 
was abrogated by granulocyte depletion. 
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8.5 Discussion 
The results showed that administration of the TLR4 ligand lipopolysaccharide 
induced elevation of granulocyte numbers in bone marrow. These changes peaked 
after 7 days and waned after 15 days. A bacterial infection during this period was 
controlled by early bacterial clearance and resulted in increased survival of LPS-
pretreated mice.  
This “memory” like prolonged resistance is granulocyte dependent and lasts at least 
for some 7 days. T cell dependent macrophage activation is often dependent on 
persisting antigen by intracellular bacteria or virus antigens and could last long, while 
the innate resistance-memory is of limited duration. What is not clear from our 
experiments, is whether granulocytes from LPS-treated mice show higher 
bactericidal activity. Interestingly, it has been shown that even when mice are 
immunized against L.m., the killing activity of early granulocytes does not differ from 
that of naïve controls. Only the number of phagocytes that can be recruited is much 
higher in immune mice (Czuprynski, Henson et al. 1984; Czuprynski, Henson et al. 
1985). Taken together, our observation suggest an addition and widening of the 
“hygiene hypothesis”: LPS and probably other TLR ligands can activate innate 
immunity for 5-7 days, enhancing protection against bacterial superinfection.  
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8.7 Figure legends 
Fig. 1: LPS induces granulocyte-dependent antibacterial resistance  
(A) Numbers of Ly6G+CD11b+ (red), Ly6C+CD11b+Ly6G- (black), and Ly6G-
CD11b- cells (green) after administration of 300μg LPS i.v. (n=3-4 per timepoint). 
(B) Mean fluorescence intensity of I-Ab, CD80 and CD86 on live F4/80+ cells at 
day 7 after administration of LPS (Mean +/- SEM, n=4-5, one of two experiments). 
(C) Experimental protocol (D) Bacterial organ titers at day 3 of infection with 104 
cfu L.m.  monocytogenes with or without administration of 100 μg anti-GR1 i.v. 24 
hours after infection. (Mean +/- SEM, n=3). (E) Survival curve of mice infected 
with 3x104 or 5x104 L.m. 7 days after LPS or PBS treatment (n=4 per group, one 
of two experiments). 
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9. Discussion 
 
We have analysed granulocyte kinetics in four different situations. First, a bacterial 
infection was administrated and analysed. Next, a virus infection was given prior to 
the bacterial infection. As third approach, systemic administration of a TLR2 ligand 
and its effects on a bacterial infection was analysed. Lastly, we analysed the effects 
of TLR4 stimulation prior to bacterial infection. Taken together, we observed that 
changes in the bone marrow granulocyte reserve influenced bacteria clearance.  
To put these findings into some perspectives, I would like to pose some general 
questions about immunology and later in the chapter discuss implications of the 
different findings. 
 
1. How can a host best inhibit an unknown infectious pathogen? 
2. How can the host protect its offspring during the early phase of 
immunoincompetence? 
 
The answer to the first question is to react with speed and a low threshold to any 
foreign antigen that can easily be recognised as such. This detection must be 
provided by receptors that are constitutively expressed on many cells, so that a quick 
reaction can result. Receptors that fulfill this requirement are the pattern recognition 
receptors. Their expression is widespread and they are non-clonal (Muzio, Bosisio et 
al. 2000; Janeway and Medzhitov 2002). As soon as a clearly foreign molecule, i.e. a 
bacterial lipopeptide or lipopolysaccharide that is not expressed by the host binds to 
such a receptor, the immune system can be safely activated without danger of 
autoimmunity. Clonal receptors such as the T or B cell receptor are not useful for this 
purpose as in the naïve state, only a few of these express the same receptor.  
 
Speed and low threshold of reactivity 
Why are speed and a low threshold probably very important? If one looks at the 
problem from the pathogen’s point of view, its main goal is to quickly establish a 
persistent infection in the host. This must be done without being noticed for as long 
as possible to multiply and invade the host’s tissues, so that the chances of being 
cleared decrease over time. Because pathogens also undergo evolution, the 
respective pathogens abilities to achieve a quick and stealthy infection were selected  
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for during the co-existence of host and parasites. Therefore, during evolution of 
pathogens, they will be selected for low triggering of pattern recognition receptors 
and for quick establishment of a persistent infection. These selected abilities need to 
be countered by a low threshold of activation and quick reaction by the host if he is to 
survive.  
A constant supply of mobile phagocytes must be maintained 
What are the implications of a low threshold for activation? If the host has to provide 
a quick immunological reaction to every bacterial infection, a constant arsenal of 
antibacterial mediators must be at ready disposition. Pathogens not previously 
encountered cannot be instantly countered with reactions by B cells or T cells. 
Therefore, a high number of ready-to-go phagocytes are needed to react quickly to 
any foreign antigen. This system of mobile phagocytes has such a low threshold of 
reaction that activated granulocytes infiltrate target organs very quickly (within 12 
hours) even if i.e. only few bacteria reach the liver.  
High reactivity can result in vulnerability to overactivation 
However, if we assume that a high reactivity to foreign antigens is indeed beneficial, 
what are the disadvantages? If a system is fine-tuned for reactions to low antigen 
loads, it does not necessarily mean that it will be able to compensate sudden high 
amounts of antigen. For example, if the granulocytes have a low threshold of reacting 
against lipopeptides because they are anticipating bacterial infection, then what 
would happen if such a lipopeptide entered the systemic circulation? Quite possibly, 
the granulocytes would be activated all at once - and this is what we observed in 
chapter 7 when the TLR2 ligand Pam2Cys was administered intravenously. That a 
generalized activation of granulocytes could be a common and dangerous situation 
becomes clear if one thinks about the phenomenon of sepsis, which is defined as 
bacteria in the circulation eliciting a systemic response. Surprisingly, the susceptibility 
to a bacterial infection was greatly increased after administration of Pam2Cys. As 
explanation, we found that not only were granulocytes activated, in fact there were 
almost no granulocytes left in the bone marrow to supply the active abscesses in the 
liver. In humans during sepsis / SIRS two phases can be distinguished, defined by 
leukocytes above 12000 or below 4000 per  μl blood. Therefore, the systemic 
response by circulating bacteria or bacterial products can have differential effects on 
leukocyte counts. 
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Therefore, the price for high reactivity to a low antigen load might be that 
overactivation can result quite easily and lead to temporary exhaustion of the 
response. If the bone marrow granulocytes were harder to activate, perhaps the 
chances would be that a dangerous peripheral bacterial infection were ignored until 
too late? 
Latency to downregulate innate activation can be advantageous 
To have continued activation of the antibacterial mechanisms after clearing the 
infection could be an additional mechanism to help overcome infections. If the host 
has been infected with an unknown pathogen in his habitat, right after the infection 
the chances could be higher to encounter a second infection either from the same or 
even another pathogen. It is known that new infectious diseases arise during habitat 
changes either from the habitats side such as temperature, weather, migrating 
animals (Shope 1991), or from the hosts side such as migration (Diamond 1997). It is 
therefore feasible that after clearance of an infection, it were of some advantage if 
the host’s defence remained activated for a while.  
There are two possibilities to do this. The first would be to leave phagocytes 
increased in numbers and reactivity. Evidence for such a relatively short-lived 
mechanism was found when Lipopolysaccharide was administrated and granulocyte 
numbers counted later 7 days later (chapter 8). Such unspecific mechanisms could 
have the advantage that the defence could be increased against every infection that 
can be recognized by pattern recognition receptors expressed on granulocytes.  
Maintenance of immune responses uses energy – innate more than adaptive 
Any bacterial or even viral infection could possibly be stopped better if phagocytes 
were increased, but only with some costs to the host. Although plants do not have 
mobile phagocytes, it has been known for a long time that in plants, mechanisms 
exists that result in generalized resistance (van Loon 1977; Kachroo, Chandra-
Shekara et al. 2006). However, when one experimentally tried to induce this 
mechanism constitutively in harvest plants, it was found that they did not grow well 
anymore, apparently having invested too much energy in the defence mechanism 
(Kaniewski and Thomas 1999). The same could theoretically be true for having 
granulocyte numbers constitutively elevated and/or activated. 
The second mechanism of lasting protection is well known – it is to prime memory T 
or B cells and keep them stored until a second infection results. This mechanism has 
the advantage that probably only little energy has to be invested. The disadvantage  
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is that the memory T cells are antigen-specific and cannot be used against a new 
infection. However, T cell dependent macrophages represent longer term effective 
“unspecific” resistance mechanisms. The same is true for having specific B cells that 
secrete antibodies – they work only against known infections. However, both T and B 
cells are very energy-efficient and have therefore possibly evolved out of more non-
specific general but energy-wasting defence mechanisms (Li, Barreda et al. 2006). A 
host without B or T cells in an environment where he repeatedly encounters the 
same infection, he would have to constantly undergo full-fledged 
granulocyte/macrophage activation if he did not have T and B cells. With an adaptive 
immune system, only the specific T cells and a few phagocytes need to be activated 
to control a second infection.  
It has been debated why memory T cells should be necessary (Zinkernagel 2003). 
When the organism has survived an infection the first time, his chances are very high 
to survive it a second time – therefore, T cell memory is possibly not crucial for the 
survival of the individual, at least until reproduction. However, one may speculate be 
that energy consumption makes a crucial difference – if an organism has T cell 
memory, he does not need full-fledged granulocyte/macrophage activation every time 
a pathogen is encountered anew, but only a specific adaptive immune response. 
Therefore, more energy remains for reproduction and raising offspring.   
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Maternal antibodies offer transmissible protection  
So what could be the answer to the second question - how to best to protect 
offspring? It has been observed that calves having received no colostrum after birth 
died from many infections. It has later been found that maternal antibodies produced 
by the mother are transmitted to the offspring transplacentally and by mothers milk 
(Gitlin, Hitzig et al. 1956; Brambell 1966; Plotkin 2001). These antibodies reflect the 
spectrum of antigens that the mother has encountered up to pregnancy. If the 
offspring receive these antibodies, a temporary protection ensues that lasts for 6-24 
months in humans and much shorter in mice. However, after this period, due to the 
20 day half-life of the antibodies, the antibody titers drop below protective values.  
Mothers milk can turn deadly infections in vaccinations  
Thereafter, the offspring have to depend on their own immune system and undergo 
all the infections anew. Interestingly, maternal antibodies can attenuate all antibody-
susceptible infectious diseases during the first months of life – but usually do not lead 
to total inactivation of the pathogens. This could be an appropriate setting for 
developing the offsprings own immunity against a pathogen. It could mean that the 
offspring could benefit from other members of the population suffering from a 
contagious infectious disease because with frequent contacts, the offspring could be 
effectively vaccinated. If none of these pathogens were circulating in the population, 
they would not have the chance to encounter it during the period of protection and 
would not develop protective immunity. In this manner, the population as a whole 
could profit from having some members which are weak and still harbour infectious 
agents. We have performed experiments that involved exposure of maternally 
protected pups to otherwise lethal virus infections (see Chapter 12) and found that 
long-lasting immunity resulted.  
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Interferon type I and bone marrow granulocytes 
We observed that IFN I action can reduce granulocyte numbers and facilitate 
superinfection. If these results are generalized, it could mean that during every 
antiviral response with high IFN I levels, granulocytopenia results in the bone 
marrow. How are these negative effects on granulocytes mediated? The main effect 
of IFN alpha and beta has been shown to be inhibition of virus transcription, 
activating RNA degradation, upregulating MHC class I and slowing or stopping the 
cell cycle (Voutsadakis 2000; Caraglia, Vitale et al. 2004; Kuchtey, Chefalo et al. 
2005). Further, it is known that IFN I can be used to treat hairy cell leukaemia 
effectively, where it induces apoptosis (Baker, Pettitt et al. 2002). Therefore, it could 
be that the granulotoxic effects we observed could be due to similar mechanisms as 
apoptosis induced in hairy cell leukaemia cells by IFN I.  
Biological role of granulotoxic effect of IFN I is unclear 
It would be interesting to know whether apoptosis induction in bone marrow 
granulocytes by IFN I has a biological reason or not. It is not clear from our results 
whether the granulocytes are directly targeted by IFN I or whether this reflects only 
an extreme situation. Further, it remains unknown whether this effect has been 
selected for by evolution. It could be that the granulocytes, which are the cells with 
the highest turnover in the hematopoietic system, are more sensitive to disturbance 
than other cells to i.e. cell cycle interruption and undergo apoptosis when their cell 
cycle is blocked by IFN I. It could also be that the virus follows an early overactivation 
strategy that results in eventual immunosuppression. In the model of IFN I receptor 
knockout mice that we used for superinfection, the mice did not show granulocyte 
apoptosis and overcame the superinfection with L.m. much better than wildtype mice. 
Therefore, absence of IFN I signalling is an advantage in this situation. However, 
these mice do no clear the virus and become carriers of noncytopathic viruses. In 
addition, when infected with a cytopathic virus such as VSV, they die within 2 days. 
Therefore, a functional IFN I signalling is of benefit. However, viruses could use this 
negative side-effect on hematopoiesis to induce temporary immunosuppression for 
establishing infections.  
Granulocyte suppression could be common during virus infections 
We believe that it could be of great benefit to measure some parameters of 
granulocyte activation and apoptosis in patients that are immunosuppressed. This 
could be done in virus infections where superinfections are regularly seen, i.e. in HIV  
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infection where also bone marrow suppression has often been observed and has not 
been explained as yet. Also, it would be interesting to analyse bone marrow samples 
of early influenza and measles patients - however, because of ethical reasons, this is 
difficult. The granulocyte count in the blood during influenza infection has been 
observed to be increased (Douglas, Alford et al. 1966) or lowered (Lewis, Gilbert et 
al. 1986). However, we believe the timepoint of measuring the granulocyte count is 
probably crucial. In the more conventional viewpoint of adaptive immunology, the 
short term kinetics can often be omitted to some extent because many effects are 
long-lasting. Indeed, also in LCMV infection, a bone marrow granulocytosis results 
eventually, but the window of opportunity that enhances superinfections comes early 
after infection.  
Circulating bacterial products induce immunosuppression 
Undue granulocyte activation can have detrimental effects not only during virus 
infection, but also during circulation of bacterial products. We observed that after 
injection of Pam2Cys, a synthetic ligand derived from a cell membrane component of 
mycoplasma, the bone marrow granulocytes were reduced by 95%. It has been 
observed long ago that circulation of bacterial products is detrimental for the immune 
response. Lipopolysaccharide leads to systemic overactivation that involves high 
secretion of TNF-α, hypercirculation and eventual blood pressure insufficiency and 
shock. Several clinical studies have been performed with anti-LPS antibodies 
(McCloskey, Straube et al. 1994) or anti-TNF antibodies (Abraham, Wunderink et al. 
1995) to antagonize these effects. However, no clear benefits for patients resulted; 
therefore these agents are not in regular use. We have not tried anti-Pam2Cys 
antibodies or anti-TLR2 antibodies in our model and presume that these could have 
beneficial effects, but only because we stimulate only TLR2.  
It should be kept in mind that a regular bacterial infection has probably several 
hundred different pattern recognition receptor activating molecules – therefore to give 
only anti-LPS during sepsis seems a too narrow an approach. In addition, a systemic 
cytokine storm involves many different cytokines that can lead to detrimental 
outcome. In our model, we have investigated whether the bone marrow suppression 
with Pam2Cys is mediated by TNF-α signalling or IFN I or II. However, bone marrow 
granulocytes were suppressed in TNF-Receptor 1 knockout mice after Pam2Cys 
treatment just as in wildtype mice. The same was true for IFN I Receptor and IFN II 
knockout mice. Therefore, bone marrow suppression by Pam2Cys is not due to one  
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of these cytokines alone. Even if a single cytokine could be identified to be mainly  
responsible for detrimental effects, both anti-IFN I treatment and anti-TNF or -LPS 
treatments are probably double-edged and very difficult to handle: Too much anti-IFN 
I could help virus persistence, too much anti-TNF lower antibacterial responses.  
G-CSF is upregulated during bone marrow granulocyte suppression 
During sepsis, also GM-CSF treatments have been tried in clinical studies. However, 
this was found to have no beneficial effect (Root, Lodato et al. 2003). In our models 
of granulocyte suppression, we have never observed a lack of G-CSF, the main 
cytokine responsible for granulopoiesis – in fact, as soon as some granulocyte loss 
occurred, G-CSF was upregulated rapidly. This could mean that additional GM-CSF / 
G-CSF administration during sepsis is futile and granulocyte numbers need to be 
preserved by other means.   
Lasting granulocyte-dependent resistance 
When we activated granulocytes and waited for 7 days, we observed that the 
numbers in the bone marrow were strongly increased after being suppressed early 
on (Chapter 9). Not surprisingly, at this timepoint a bacterial infection was cleared 
more effectively than in the non-stimulated state. The interesting aspect of this 
experiment is that 7 day long changes can be produced in the innate immune system 
by a single stimulation. That this could have been expected is obvious, but so far has 
never been analysed further – instead, innate stimuli are usually given only as 
adjuvants to induce some adaptive immune response, and the response by 
phagocytes are no matter neglected. However, we believe that this mechanism could 
have some important implications. For example, as the numbers of all granulocytes 
are increased, it could be expected that the response against most bacteria who are 
cleared by granulocytes are ameliorated. Therefore, if there were a way to induce a 
therapeutic granulocytosis, this would be of great benefit i.e. before visceral surgery, 
in patients in danger of nosocomial infections.  
Blood and bone marrow granulocyte numbers are not always congruent 
Great variability was observed when the relationship between granulocyte numbers 
in the blood and in the bone marrow was analysed. On one hand, we found that 
during bone marrow granulocytopenia, there were still some granulocytes left in the 
blood. On the other hand, granulocyte numbers did not de- or increase dramatically 
in the blood during periods when the bone marrow was depleted of granulocytes and 
they were found apoptotic in the spleen. Unfortunately, this represents a difficulty for 
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human studies, as for the analysis of these mechanisms, one would have to resort to 
bone marrow biopsies.  
Alterations of the factors influencing granulocyte transit could explain these 
inconsistencies. It is known that upregulation of integrins on endothelium and 
chemotactic signals from inflamed tissues can strongly influence granulocyte 
migration (Cinamon, Shinder et al. 2004).  Possibly, these signals can be so highly 
expressed that the half-life of granulocyte shortens, and high numbers of 
granulocytes leaving the bone marrow can stay undetected as during the infection 
with L.m.  
No single chemokine or receptor responsible for granulocyte homing 
It would also be very interesting to know which molecules are responsible for 
chemotaxis of granulocytes to sites of infection. It is known that chemokines are 
partly responsible, but no knockout approach of any molecule has so far yielded an 
absence of granulocytic infiltration.  The ß2-integrin CD11b measured here as an 
activation marker has a role in granulocytic adherence to endothelium. However, it 
can be safely deleted without impairing granulocyte homing. Instead, as could be 
expected, granulocyte activation, phagocytosis, and attachment to glass surfaces is 
impaired. Consistent with the observation that activation of granulocytes induces 
apoptosis, CD11b knockout granulocytes demonstrate decreased activation and 
decreased apoptosis.  
 
Taken together, analysis of granulocyte kinetics in man could yield new insights to 
better understand superinfection and sepsis. If inappropriate activation of 
granulocytes could be attenuated, the infections with pathogens where granulocytes 
play a significant role could be overcome more easily, and this may extend to 
bacteria resistant to antibiotics. 
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Exposure to a lethal virus infection during maternal antibody protection can 
act as vaccination 
 
(manuscript in preparation) 
 
Navarini AA, Krzyzowska M, Recher M, Lang KS, Verschoor A, Hengartner H, 
Niemialtowski M and RM Zinkernagel 
 
Abstract 
Maternal antibodies have a recognized important role in conferring protection to the 
newborn against viruses the mother has already encountered. We demonstrate here 
that mice repeatedly exposed to a lethal dose of vaccinia virus survive when 
protected by maternal antibodies and generate their own protection. When later in life 
a challenge with the cross-reactive ectromelia virus was performed, only the mice 
exposed to vaccinia virus as pups survived while unexposed mice died. When 
maternal protection is available, then encountering a deadly virus infection early in 
life mediates vaccination via attenuation if repeated, with a huge impact on survival 
. 
Contribution: AA Navarini performed all experiments except virus challenge of adult 
mice. 
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infection 
 
(manuscript in preparation) 
 
Navarini AA, Lang KS, Recher M, Odermatt B, Hengartner H and R.M. Zinkernagel 
 
Abstract 
Flt-3L is known to be centrally implicated in hematopoiesis of dendritic cells. 
Knockout mice for this cytokine harbor dramatically lower dendritic cell counts than 
wildtype mice, leading to decreased sentinel functions of dendritic cells. Treatment of 
wildtype mice with recombinant Flt3L has been shown to increase resistance to the 
gram-positive bacterium Listeria monocytogenes in secondary infection of adult mice, 
and during infection of newborns.  However, increased dendritic cell counts have also 
been reported to impair primary anti-listerial responses. Here we demonstrate that 
Flt3L knockout mice harbor less interferon I producing dendritic cells, have lower 
amounts of type I interferon in serum upon Listeria monocytogenes infection and are 
more than a 100-fold more resistant than wildtype mice during primary challenge. 
When Flt3L-/- mice were treated with recombinant Flt3L, susceptibility could be 
partially restored.  
 
Contribution: AA Navarini performed all experiments. 
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Verschoor A*, Navarini AA*, Hengartner H and R.M. Zinkernagel 
 
Abstract 
Complement deficiency has been identified as an immune defect that predisposes 
patients to purulent infections. Here we demonstrate that for the intracellular 
bacterium Listeria monocytogenes, complement 3 and 4 deficiency leads to 
increased clearance of bacteria after 3 days. This is associated with increased 
granulocyte numbers in complement deficient mice. During the whole period of 
infection, granulocytes were elevated in complement deficient mice compared to 
controls. Further, L.m. showed decreased homing to complement deficient liver 
macrophages. These macrophages have only low bactericidal function and constitute 
a reservoir for L.m. to propagate within. With administration of cobra venom factor, 
we could inhibit L.m. homing to macrophages and induce anti-listerial resistance 
comparable to C3-/- mice.  
 
Contribution: AA Navarini for half of all experiments. 
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Falsig J, Navarini AA, Zinkernagel RM and A. Aguzzi 
 
Abstract 
Vesicular stomatitis virus is neurotropic and cytopathic with an intracerebral LD50 of 
1-5 pfu. We have asked whether the brain cells are unprotected because innate 
reactivity is lacking. We observed that live cerebral tissue sections treated with 
interferon type I could be protected against VSV infection. However, they did not 
produce a significant amount of IFN I when inoculated with VSV or when treated with 
irradiated VSV particles. When they were stimulated with Poly(I:C), cerebral slices 
produced IFN I and were protected against VSV infection. Depletion of microglia did 
not abrogate this effect, therefore also other cerebral cells are capable of mediating 
this protection. When pure astrocyte and neuronal cell cultures were treated with 
Poly(I:C), they could also develop some protective function against VSV.  
 
Contribution: AA Navarini performed infection experiments, titer determination and 
ELISA. 
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signaling  
 
J Clin Invest. 2006 Sep;116(9):2456-63. 
  
Lang KS, Georgiev P, Recher M, Navarini AA, Bergthaler A, Heikenwalder M, Harris 
NL, Junt T, Odermatt B, Clavien PA, Pircher H, Akira S, Hengartner H, Zinkernagel 
RM.  
 
Abstract 
The liver is known to be a classical immunoprivileged site with a relatively high 
resistance against immune responses. Here we demonstrate that highly activated 
liver-specific effector CD8+ T cells alone were not sufficient to trigger immune 
destruction of the liver in mice. Only additional innate immune signals orchestrated 
by TLR3 provoked liver damage. While TLR3 activation did not directly alter liver-
specific CD8+ T cell function, it induced IFN-α and TNF-α release. These cytokines 
generated expression of the chemokine CXCL9 in the liver, thereby enhancing CD8+ 
T cell infiltration and liver disease in mice. Thus, nonspecific activation of innate 
immunity can drastically enhance susceptibility to immune destruction of a solid 
organ. 
 
Contribution: AA Navarini performed one of the mouse experiments with 
administration of pertussis toxin to block chemokine signalling. 
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Cholestasis protects the liver from ischaemic injury and post-ischaemic 
inflammation in the mouse 
 
Gut. 2006 Jun 8 
 
Georgiev P, Navarini AA, Eloranta JJ, Lang KS, Kullak-Ublick GA, Nocito A, Dahm 
F, Jochum W, Graf R, Clavien PA.  
 
Abstract 
Cholestasis is associated with high morbidity and mortality rates in patients 
undergoing major liver surgery, but the responsible mechanisms remain elusive. 
Increased ischaemic liver injury and inflammation might contribute to the poor 
outcome. Common bile duct ligation (biliary obstruction with hyperbilirubinemia) or 
selective ligation of the left hepatic duct (biliary obstruction without 
hyperbilirubinemia) was performed in C57BL/6 mice prior to 1h of hepatic ischaemia 
and 1, 4 or 24h of reperfusion. Infection with the intracellular hepatic pathogen 
Listeria monocytogenes for 12 and 48h was used to study ischaemia-independent 
hepatic inflammation. Unexpectedly, cholestatic mice displayed significant protection 
from ischaemic liver injury as determined by transaminase release, histological liver 
injury, and neutrophil infiltration. In cholestatic mice, reduced injury correlated with a 
failure to activate NF-eB and TNF-α mRNA synthesis, two key mediators of 
postischaemic liver inflammation. After selective bile duct ligation, both the ligated 
and the non-ligated lobes displayed blocked activation of NF-eB as well as reduced 
induction of TNF-α mRNA synthesis and neutrophil infiltration. In contrast, infection 
with Listeria monocytogenes revealed comparable activation of NF-eB and hepatic 
recruitment of neutrophils 12h after infection. Cholestasis does not enhance but 
rather dramatically protect from ischaemic liver injury and inflammation. This effect is 
mediated by a systemic factor, but not bilirubin, and is associated with a preserved 
capacity to trigger an inflammatory response to other stimuli such as a bacterial 
pathogen. 
 
Contribution: AA Navarini performed all experiments with Listeria monocytogenes 
infection. 
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Inverse correlation between IL-7 receptor expression and CD8 T cell 
exhaustion during persistent antigen stimulation 
 
Eur J Immunol. 2005 Mar;35(3):738-45.  
 
Lang KS*, Recher M*, Navarini AA*, Harris NL, Lohning M, Junt T, Probst HC, 
Hengartner H, Zinkernagel RM. (* shared first authors) 
 
Abstract 
Persistence is a hallmark of infection by viruses such as HIV, hepatitis B virus, 
hepatitis C virus and LCMV. In the case of LCMV, persistence may often be 
associated with exhaustion of CD8(+) T cells. We demonstrate here that persistent 
antigen suppressed IL-7Rα expression and this correlated with T cell exhaustion and 
reduced expression of the anti-apoptotic molecule B cell leukemia/lymphoma 2 (Bcl-
2). In contrast, exposure to short-lived antigen only temporarily suppressed IL-7Rα 
expression, failed to induce T cell exhaustion, and primed T cells. Persistent antigen 
also suppressed IL-7Rα expression on primed T cells and this correlated with 
exhaustion of a previously stable primed T cell population. These findings suggest 
that antigen longevity regulates T cell fate. 
 
Contribution: AA Navarini contributed the concept of the IL-7R downregulation and 
performed FACS analysis. 
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Requirement for neutralizing antibodies to control bone marrow 
transplantation-associated persistent viral infection and to reduce 
immunopathology 
 
J Immunol. 2005 Oct 15;175(8):5524-31. 
 
Lang KS*, Recher M*, Navarini AA*, Freigang S, Harris NL, van den Broek M, 
Odermatt B, Hengartner H, Zinkernagel RM. (* shared first authors) 
 
Abstract 
Bone marrow transplantation (BMT) is commonly used in the treatment of leukemia, 
however its therapeutic application is partly limited by the high incidence of 
associated opportunistic infections. We modeled this clinical situation by infecting 
mice that underwent BMT with lymphocytic choriomeningitis virus (LCMV) and 
investigated the potential of immunotherapeutic strategies to counter such infections. 
All mice that received BMT survived LCMV infection and developed a virus carrier 
status. Immunotherapy by adoptive transfer of naive splenocytes protected against 
low (200 PFU), but not high (2 x 10(6) PFU), doses of LCMV. Attempts to control 
infection of high viral titers using strongly elevated frequencies of activated LCMV-
specific T cells failed to control virus and resulted in immunopathology and death. In 
contrast, virus neutralizing Abs combined with naive splenocytes were able to 
efficiently control high-dose LCMV infection without associated side effects. Thus, 
cell transfer combined with neutralizing Abs represented the most effective means of 
controlling BMT-associated opportunistic viral infection in our in vivo model. These 
data underscore the in vivo efficacy and immunopathological "safety" of neutralizing 
antibodies. 
 
Contribution: AA Navarini performed the experiments with transfer of hyperimmune 
serum to prevent immunopathology (Fig. 7). 
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Toll-like receptor engagement converts T-cell autoreactivity into overt 
autoimmune disease  
 
Nat Med. 2005 Feb;11(2):138-45. 
 
Lang KS, Recher M, Junt T, Navarini AA, Harris NL, Freigang S, Odermatt B, 
Conrad C, Ittner LM, Bauer S, Luther SA, Uematsu S, Akira S, Hengartner H, 
Zinkernagel RM.  
 
Abstract 
Autoimmune diabetes mellitus in humans is characterized by immunological 
destruction of pancreatic beta islet cells. We investigated the circumstances under 
which CD8(+) T cells specific for pancreatic beta-islet antigens induce disease in 
mice expressing lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP) as a 
transgene under the control of the rat insulin promoter. In contrast to infection with 
LCMV, immunization with LCMV-GP derived peptide did not induce autoimmune 
diabetes despite large numbers of autoreactive cytotoxic T cells. Only subsequent 
treatment with Toll-like receptor ligands elicited overt autoimmune disease. This 
difference was critically regulated by the peripheral target organ itself, which 
upregulated class I major histocompatibility complex (MHC) in response to systemic 
Toll-like receptor-triggered interferon-α production. These data identify the 
'inflammatory status' of the target organ as a separate and limiting factor determining 
the development of autoimmune disease. 
 
Contribution: AA Navarini performed the experiments with IFNAR-/- x RIP-GP and 
LCMV infection (Fig. 6). 
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Deliberate removal of T cell help improves virus-neutralizing antibody 
production. 
 
Nat Immunol. 2004 Sep;5(9):934-42.  
 
Recher M, Lang KS, Hunziker L, Freigang S, Eschli B, Harris NL, Navarini A, Senn 
BM, Fink K, Lotscher M, Hangartner L, Zellweger R, Hersberger M, Theocharides A, 
Hengartner H, Zinkernagel RM.  
 
Abstract 
The B cell response to lymphocytic choriomeningitis virus is characterized by a 
CD4(+) T cell-dependent polyclonal hypergammaglobulinemia and delayed formation 
of virus-specific neutralizing antibodies. Here we provide evidence that, 
paradoxically, because of polyclonal B cell activation, virus-specific T cell help 
impairs the induction of neutralizing antibody responses. Experimental reduction in 
CD4(+) T cell help in vivo resulted in potent neutralizing antibody responses without 
impairment of CD8(+) T cell activity. These unexpected consequences of polyclonal B 
cell activation may affect vaccine strategies and the treatment of clinically relevant 
chronic bacterial, parasitic and viral infections in which hypergammaglobulinemia is 
regularly found. 
 
Contribution: AA Navarini helped with several of the experiments. 
 
 
